{
  "Version": 76,
  "Individuals": [
    {
      "Name": "Agarwala2003",
      "Seed": 99551117,
      "OriginData": {
        "CalculationMethods": [
          "SurfaceAreaPlsInt_VAR1",
          "Body surface area - Mosteller"
        ],
        "Species": "Human",
        "Population": "WhiteAmerican_NHANES_1997",
        "Gender": "MALE",
        "Age": {
          "Value": 30.0,
          "Unit": "year(s)"
        }
      },
      "Molecules": [
        {
          "Name": "CYP3A4",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Brain",
              "Value": 0.0041682898325
            },
            {
              "Name": "Gonads",
              "Value": 0.00078691079081
            },
            {
              "Name": "Kidney",
              "Value": 0.0053603428126
            },
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "Value": 0.00042695753798
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.0727697702
            },
            {
              "Name": "Duodenum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperIleum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerIleum",
              "Value": 0.0727697702
            }
          ],
          "Ontogeny": {
            "Name": "CYP3A4"
          }
        }
      ]
    },
    {
      "Name": "Agarwala2005a",
      "Seed": 99657026,
      "OriginData": {
        "CalculationMethods": [
          "SurfaceAreaPlsInt_VAR1",
          "Body surface area - Mosteller"
        ],
        "Species": "Human",
        "Population": "MexicanAmericanWhite_NHANES_1997",
        "Gender": "MALE",
        "Age": {
          "Value": 26.0,
          "Unit": "year(s)"
        }
      },
      "Molecules": [
        {
          "Name": "CYP3A4",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Brain",
              "Value": 0.0041682898325
            },
            {
              "Name": "Gonads",
              "Value": 0.00078691079081
            },
            {
              "Name": "Kidney",
              "Value": 0.0053603428126
            },
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "Value": 0.00042695753798
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.0727697702
            },
            {
              "Name": "Duodenum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperIleum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerIleum",
              "Value": 0.0727697702
            }
          ],
          "Ontogeny": {
            "Name": "CYP3A4"
          }
        }
      ]
    },
    {
      "Name": "Agarwala2005b",
      "Seed": 99725854,
      "OriginData": {
        "CalculationMethods": [
          "SurfaceAreaPlsInt_VAR1",
          "Body surface area - Mosteller"
        ],
        "Species": "Human",
        "Population": "WhiteAmerican_NHANES_1997",
        "Gender": "MALE",
        "Age": {
          "Value": 35.0,
          "Unit": "year(s)"
        }
      },
      "Molecules": [
        {
          "Name": "CYP3A4",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Brain",
              "Value": 0.0041682898325
            },
            {
              "Name": "Gonads",
              "Value": 0.00078691079081
            },
            {
              "Name": "Kidney",
              "Value": 0.0053603428126
            },
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "Value": 0.00042695753798
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.0727697702
            },
            {
              "Name": "Duodenum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperIleum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerIleum",
              "Value": 0.0727697702
            }
          ],
          "Ontogeny": {
            "Name": "CYP3A4"
          }
        }
      ]
    },
    {
      "Name": "Martin2008",
      "Seed": 99803730,
      "OriginData": {
        "CalculationMethods": [
          "SurfaceAreaPlsInt_VAR1",
          "Body surface area - Mosteller"
        ],
        "Species": "Human",
        "Population": "WhiteAmerican_NHANES_1997",
        "Gender": "MALE",
        "Age": {
          "Value": 32.9,
          "Unit": "year(s)"
        },
        "Weight": {
          "Value": 87.6,
          "Unit": "kg"
        },
        "Height": {
          "Value": 172.8,
          "Unit": "cm"
        }
      },
      "Molecules": [
        {
          "Name": "CYP3A4",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Brain",
              "Value": 0.0041682898325
            },
            {
              "Name": "Gonads",
              "Value": 0.00078691079081
            },
            {
              "Name": "Kidney",
              "Value": 0.0053603428126
            },
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "Value": 0.00042695753798
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.0727697702
            },
            {
              "Name": "Duodenum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperIleum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerIleum",
              "Value": 0.0727697702
            }
          ],
          "Ontogeny": {
            "Name": "CYP3A4"
          }
        }
      ]
    },
    {
      "Name": "Zhu2011",
      "Seed": 99832356,
      "OriginData": {
        "CalculationMethods": [
          "SurfaceAreaPlsInt_VAR1",
          "Body surface area - Mosteller"
        ],
        "Species": "Human",
        "Population": "WhiteAmerican_NHANES_1997",
        "Gender": "MALE",
        "Age": {
          "Value": 30.0,
          "Unit": "year(s)"
        }
      },
      "Molecules": [
        {
          "Name": "CYP3A4",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Brain",
              "Value": 0.0041682898325
            },
            {
              "Name": "Gonads",
              "Value": 0.00078691079081
            },
            {
              "Name": "Kidney",
              "Value": 0.0053603428126
            },
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "Value": 0.00042695753798
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.0727697702
            },
            {
              "Name": "Duodenum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperIleum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerIleum",
              "Value": 0.0727697702
            }
          ],
          "Ontogeny": {
            "Name": "CYP3A4"
          }
        }
      ]
    },
    {
      "Name": "WhiteAmericanMale",
      "Seed": 174062452,
      "OriginData": {
        "CalculationMethods": [
          "SurfaceAreaPlsInt_VAR1",
          "Body surface area - Mosteller"
        ],
        "Species": "Human",
        "Population": "WhiteAmerican_NHANES_1997",
        "Gender": "MALE",
        "Age": {
          "Value": 30.0,
          "Unit": "year(s)"
        }
      },
      "Molecules": [
        {
          "Name": "CYP3A4",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Brain",
              "Value": 0.0041682898325
            },
            {
              "Name": "Gonads",
              "Value": 0.00078691079081
            },
            {
              "Name": "Kidney",
              "Value": 0.0053603428126
            },
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "Value": 0.00042695753798
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.0727697702
            },
            {
              "Name": "Duodenum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperIleum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerIleum",
              "Value": 0.0727697702
            }
          ],
          "Ontogeny": {
            "Name": "CYP3A4"
          }
        }
      ]
    },
    {
      "Name": "WhiteAmericanFemale",
      "Seed": 195774031,
      "OriginData": {
        "CalculationMethods": [
          "SurfaceAreaPlsInt_VAR1",
          "Body surface area - Mosteller"
        ],
        "Species": "Human",
        "Population": "European_ICRP_2002",
        "Gender": "FEMALE",
        "Age": {
          "Value": 30.0,
          "Unit": "year(s)"
        }
      },
      "Molecules": [
        {
          "Name": "CYP3A4",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Brain",
              "Value": 0.0041682898325
            },
            {
              "Name": "Gonads",
              "Value": 0.00078691079081
            },
            {
              "Name": "Kidney",
              "Value": 0.0053603428126
            },
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "Value": 0.00042695753798
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.0727697702
            },
            {
              "Name": "Duodenum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperIleum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerIleum",
              "Value": 0.0727697702
            }
          ],
          "Ontogeny": {
            "Name": "CYP3A4"
          }
        }
      ]
    },
    {
      "Name": "Zhu2010",
      "Seed": 20599214,
      "OriginData": {
        "CalculationMethods": [
          "SurfaceAreaPlsInt_VAR1",
          "Body surface area - Mosteller"
        ],
        "Species": "Human",
        "Population": "WhiteAmerican_NHANES_1997",
        "Gender": "MALE",
        "Age": {
          "Value": 32.0,
          "Unit": "year(s)"
        },
        "Weight": {
          "Value": 77.3,
          "Unit": "kg"
        },
        "Height": {
          "Value": 170.4704,
          "Unit": "cm"
        }
      },
      "Molecules": [
        {
          "Name": "CYP3A4",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Brain",
              "Value": 0.0041682898325
            },
            {
              "Name": "Gonads",
              "Value": 0.00078691079081
            },
            {
              "Name": "Kidney",
              "Value": 0.0053603428126
            },
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "Value": 0.00042695753798
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.0727697702
            },
            {
              "Name": "Duodenum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperIleum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerIleum",
              "Value": 0.0727697702
            }
          ],
          "Ontogeny": {
            "Name": "CYP3A4"
          }
        },
        {
          "Name": "UGT1A1",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Gonads",
              "Value": 0.0013585313175
            },
            {
              "Name": "Kidney",
              "Value": 0.0788336933
            },
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "Value": 0.00027429805616
            },
            {
              "Name": "Stomach",
              "Value": 0.016349892
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.3239740821
            },
            {
              "Name": "LargeIntestine",
              "Value": 0.0349892009
            },
            {
              "Name": "Duodenum",
              "Value": 0.3239740821
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.3239740821
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.3239740821
            },
            {
              "Name": "UpperIleum",
              "Value": 0.3239740821
            },
            {
              "Name": "LowerIleum",
              "Value": 0.3239740821
            },
            {
              "Name": "ColonAscendens",
              "Value": 0.0349892009
            },
            {
              "Name": "ColonTransversum",
              "Value": 0.0349892009
            },
            {
              "Name": "ColonDescendens",
              "Value": 0.0349892009
            },
            {
              "Name": "ColonSigmoid",
              "Value": 0.0349892009
            }
          ],
          "Ontogeny": {
            "Name": "UGT1A1"
          },
          "Parameters": [
            {
              "Name": "Reference concentration",
              "Value": 1.328,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVitro",
                "Description": "Calculated from Ohtsuki 2012 (PMID 21994437)"
              }
            }
          ]
        },
        {
          "Name": "UGT1A9",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Gonads",
              "Value": 0.00016153846154
            },
            {
              "Name": "Kidney",
              "Value": 1.0
            },
            {
              "Name": "Periportal",
              "Value": 0.0982905983
            },
            {
              "Name": "Pericentral",
              "Value": 0.0982905983
            },
            {
              "Name": "Stomach",
              "Value": 0.0017264957265
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.0041282051282
            },
            {
              "Name": "LargeIntestine",
              "Value": 0.0079487179487
            },
            {
              "Name": "Duodenum",
              "Value": 0.0041282051282
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.0041282051282
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.0041282051282
            },
            {
              "Name": "UpperIleum",
              "Value": 0.0041282051282
            },
            {
              "Name": "LowerIleum",
              "Value": 0.0041282051282
            },
            {
              "Name": "ColonAscendens",
              "Value": 0.0079487179487
            },
            {
              "Name": "ColonTransversum",
              "Value": 0.0079487179487
            },
            {
              "Name": "ColonDescendens",
              "Value": 0.0079487179487
            },
            {
              "Name": "ColonSigmoid",
              "Value": 0.0079487179487
            }
          ],
          "Ontogeny": {
            "Name": "UGT1A1"
          },
          "Parameters": [
            {
              "Name": "Reference concentration",
              "Value": 10.36,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "InVitro",
                "Description": "Calculated from Ohtsuki 2012 (PMID 21994437)"
              }
            }
          ]
        }
      ]
    },
    {
      "Name": "Acosta2007",
      "Seed": 8908561,
      "OriginData": {
        "CalculationMethods": [
          "SurfaceAreaPlsInt_VAR1",
          "Body surface area - Mosteller"
        ],
        "Species": "Human",
        "Population": "WhiteAmerican_NHANES_1997",
        "Gender": "MALE",
        "Age": {
          "Value": 34.0,
          "Unit": "year(s)"
        },
        "Weight": {
          "Value": 78.0,
          "Unit": "kg"
        }
      },
      "Molecules": [
        {
          "Name": "CYP3A4",
          "Type": "Enzyme",
          "MembraneLocation": "Apical",
          "TissueLocation": "Intracellular",
          "IntracellularVascularEndoLocation": "Endosomal",
          "Expression": [
            {
              "Name": "Brain",
              "Value": 0.0041682898325
            },
            {
              "Name": "Gonads",
              "Value": 0.00078691079081
            },
            {
              "Name": "Kidney",
              "Value": 0.0053603428126
            },
            {
              "Name": "Periportal",
              "Value": 1.0
            },
            {
              "Name": "Pericentral",
              "Value": 1.0
            },
            {
              "Name": "Lung",
              "Value": 0.00042695753798
            },
            {
              "Name": "SmallIntestine",
              "Value": 0.0727697702
            },
            {
              "Name": "Duodenum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerJejunum",
              "Value": 0.0727697702
            },
            {
              "Name": "UpperIleum",
              "Value": 0.0727697702
            },
            {
              "Name": "LowerIleum",
              "Value": 0.0727697702
            }
          ],
          "Ontogeny": {
            "Name": "CYP3A4"
          }
        }
      ]
    }
  ],
  "Compounds": [
    {
      "Name": "Atazanavir",
      "IsSmallMolecule": true,
      "Lipophilicity": [
        {
          "Name": "Measurement",
          "Parameters": [
            {
              "Name": "Lipophilicity",
              "Value": 2.12,
              "Unit": "Log Units",
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Unknown",
                "Description": "Hyland 2008, PMID: 18647303"
              }
            }
          ]
        }
      ],
      "FractionUnbound": [
        {
          "Name": "Measurement",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "Fraction unbound (plasma, reference value)",
              "Value": 0.14,
              "ValueOrigin": {
                "Source": "Publication",
                "Method": "Unknown",
                "Description": "Rajoli 2015, PMID: 25523214"
              }
            }
          ]
        }
      ],
      "Solubility": [
        {
          "Name": "Assumption",
          "Parameters": [
            {
              "Name": "Solubility at reference pH",
              "Value": 50000.0,
              "Unit": "mg/l",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from '015.02.04_CYP3A4_200mg-800mg_GFR+MBI-OPT' on 2019-07-29 13:24"
              }
            },
            {
              "Name": "Reference pH",
              "Value": 7.0,
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'Parameter Identification 5' on 2019-05-21 14:40"
              }
            }
          ]
        }
      ],
      "IntestinalPermeability": [
        {
          "Name": "Optimized",
          "Parameters": [
            {
              "Name": "Specific intestinal permeability (transcellular)",
              "Value": 9.8649602504E-06,
              "Unit": "cm/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'SingleDose' on 2019-07-29 17:45"
              }
            }
          ]
        }
      ],
      "PkaTypes": [
        {
          "Type": "Base",
          "Pka": 4.7,
          "ValueOrigin": {
            "Source": "Publication",
            "Method": "Unknown",
            "Description": "Berlin 2015, PMID: 25872159"
          }
        }
      ],
      "Processes": [
        {
          "InternalName": "MetabolizationSpecific_FirstOrder",
          "DataSource": "Optimized",
          "Molecule": "CYP3A4",
          "Parameters": [
            {
              "Name": "Enzyme concentration",
              "Value": 1.0,
              "Unit": "µmol/l"
            },
            {
              "Name": "Specific clearance",
              "Value": 0.0,
              "Unit": "1/min"
            },
            {
              "Name": "CLspec/[Enzyme]",
              "Value": 1.0383524966,
              "Unit": "l/µmol/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'SingleDose' on 2019-07-29 17:45"
              }
            }
          ]
        },
        {
          "InternalName": "NoncompetitiveInhibition",
          "DataSource": "InternalData",
          "Molecule": "UGT1A1",
          "Parameters": [
            {
              "Name": "Ki",
              "Value": 0.17,
              "Unit": "µM"
            }
          ]
        },
        {
          "InternalName": "GlomerularFiltration",
          "DataSource": "Clinical Pharmacology Review",
          "Species": "Human",
          "Parameters": [
            {
              "Name": "GFR fraction",
              "Value": 2.014495446,
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'Single+MultipleDose_withMBI' on 2019-07-30 10:12"
              }
            }
          ]
        },
        {
          "InternalName": "IrreversibleInhibition",
          "DataSource": "Perloff2005",
          "Molecule": "CYP3A4",
          "Parameters": [
            {
              "Name": "kinact",
              "Value": 0.0033009852632,
              "Unit": "1/min",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'Single+MultipleDose_withMBI' on 2019-07-30 10:12"
              }
            },
            {
              "Name": "K_kinact_half",
              "Value": 0.1292581489,
              "Unit": "µmol/l",
              "ValueOrigin": {
                "Source": "ParameterIdentification",
                "Method": "ParameterIdentification",
                "Description": "Value updated from 'Single+MultipleDose_withMBI' on 2019-07-30 10:12"
              }
            }
          ]
        }
      ],
      "CalculationMethods": [
        "Cellular partition coefficient method - Rodgers and Rowland",
        "Cellular permeability - PK-Sim Standard"
      ],
      "Parameters": [
        {
          "Name": "Molecular weight",
          "Value": 704.8555,
          "Unit": "g/mol",
          "ValueOrigin": {
            "Source": "Internet",
            "Method": "Unknown",
            "Description": "drugbank.ca"
          }
        }
      ]
    }
  ],
  "Formulations": [
    {
      "Name": "Reyataz capsule",
      "FormulationType": "Formulation_Tablet_Weibull",
      "Parameters": [
        {
          "Name": "Dissolution time (50% dissolved)",
          "Value": 78.8787658271,
          "Unit": "min",
          "ValueOrigin": {
            "Source": "ParameterIdentification",
            "Method": "ParameterIdentification",
            "Description": "Value updated from 'SingleDose' on 2019-07-29 17:45"
          }
        },
        {
          "Name": "Lag time",
          "Value": 0.0,
          "Unit": "min"
        },
        {
          "Name": "Dissolution shape",
          "Value": 1.5566465018,
          "ValueOrigin": {
            "Source": "ParameterIdentification",
            "Method": "ParameterIdentification",
            "Description": "Value updated from 'SingleDose' on 2019-07-29 17:45"
          }
        },
        {
          "Name": "Use as suspension",
          "Value": 1.0,
          "ValueOrigin": {
            "Source": "Other",
            "Method": "Other"
          }
        }
      ]
    }
  ],
  "Protocols": [
    {
      "Name": "400mg_QD_7days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 400.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 7.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "400mg_QD_6days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 400.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 6.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "400mg_QD_5days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 400.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 5.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "200mg_QD_5days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 200.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 5.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "800mg_QD_5days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 800.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 5.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "400mg_SD",
      "ApplicationType": "Oral",
      "DosingInterval": "Single",
      "Parameters": [
        {
          "Name": "Start time",
          "Value": 0.0,
          "Unit": "h"
        },
        {
          "Name": "InputDose",
          "Value": 400.0,
          "Unit": "mg"
        },
        {
          "Name": "Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ]
    },
    {
      "Name": "300mg_BID_7days_at120h",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 300.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "NumberOfRepetitions",
              "Value": 14.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 12.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "300mg_BID",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 300.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 15.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 12.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "200mg_QD_6days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 200.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 6.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "300mg_QD_10days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 300.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 10.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "TimeBetweenRepetitions",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    },
    {
      "Name": "800mg_QD_6days",
      "DosingInterval": "Single",
      "Schemas": [
        {
          "Name": "Schema 1",
          "SchemaItems": [
            {
              "Name": "Schema Item 1",
              "ApplicationType": "Oral",
              "FormulationKey": "Formulation",
              "Parameters": [
                {
                  "Name": "Start time",
                  "Value": 0.0,
                  "Unit": "h"
                },
                {
                  "Name": "InputDose",
                  "Value": 800.0,
                  "Unit": "mg"
                },
                {
                  "Name": "Volume of water/body weight",
                  "Value": 3.5,
                  "Unit": "ml/kg"
                }
              ]
            }
          ],
          "Parameters": [
            {
              "Name": "NumberOfRepetitions",
              "Value": 6.0,
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        }
      ],
      "TimeUnit": "h"
    }
  ],
  "Events": [
    {
      "Name": "High-fat breakfast",
      "Template": "Meal: High-fat breakfast (Human)"
    },
    {
      "Name": "Light meal",
      "Template": "Meal: Standard (Human)",
      "Parameters": [
        {
          "Name": "Meal energy content",
          "Value": 373.0,
          "Unit": "kcal",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        }
      ]
    }
  ],
  "Simulations": [
    {
      "Name": "Agarwala2003_400mg",
      "Model": "4Comp",
      "ObservedData": [
        "Agarwala 2003 - Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 124.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 124.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 193.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "Agarwala2003",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "400mg_QD_6days",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "Events": [
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 0.0,
            "Unit": "h"
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 23.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 47.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 71.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 95.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 119.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 115.729,
              "Max": 194.2215,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.004905615,
              "Max": 10.83339,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Agarwala2003_400mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Agarwala2003_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Agarwala 2003 - Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Agarwala 2003 - Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)|Time",
              "Y": "Agarwala 2003 - Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Atazanavir_final\nAgarwala2003_400mg\n2019-07-29 13:39"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    },
    {
      "Name": "Agarwala2005a_400mg",
      "Model": "4Comp",
      "ObservedData": [
        "Agarwala 2005a - ATV 400 mg AM (N=15) - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 124.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 124.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "Agarwala2005a",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "400mg_QD_6days",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "Events": [
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 0.0,
            "Unit": "h"
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 23.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 47.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 71.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 95.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 119.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 117.2744,
              "Max": 148.5316,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.07659008,
              "Max": 14.03444,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Agarwala2005a_400mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Agarwala2005a_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Agarwala 2005a - ATV 400 mg AM (N=15) - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Agarwala 2005a - ATV 400 mg AM (N=15) - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)|Time",
              "Y": "Agarwala 2005a - ATV 400 mg AM (N=15) - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Atazanavir_final\nAgarwala2005a_400mg\n2019-07-29 13:39"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    },
    {
      "Name": "Agarwala2005b_400mg",
      "Model": "4Comp",
      "ObservedData": [
        "Agarwala 2005b - ATV 400 mg (Treatment A) - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 124.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 124.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "Agarwala2005b",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "400mg_QD_6days",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "Events": [
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 0.0,
            "Unit": "h"
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 23.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 47.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 71.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 95.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 119.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 117.9058,
              "Max": 145.3744,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.2664433,
              "Max": 6.829753,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Agarwala2005b_400mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Agarwala2005b_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Agarwala 2005b - ATV 400 mg (Treatment A) - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Agarwala 2005b - ATV 400 mg (Treatment A) - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)|Time",
              "Y": "Agarwala 2005b - ATV 400 mg (Treatment A) - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Atazanavir_final\nAgarwala2005b_400mg\n2019-07-29 13:39"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    },
    {
      "Name": "Martin2008_400mg",
      "Model": "4Comp",
      "ObservedData": [
        "Martin 2008 - Atazanavir monotherapy (n = 24) - Atazanavir - PO - 400 mg - Plasma - agg. (n=24)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 148.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 148.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 168.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|400mg_QD_7days|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_7days|Reyataz capsule|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_7days|Reyataz capsule|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_7days|Reyataz capsule|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_7days|Reyataz capsule|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_7days|Reyataz capsule|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_7days|Reyataz capsule|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "Martin2008",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "400mg_QD_7days",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "Events": [
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 0.0,
            "Unit": "h"
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 23.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 47.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 71.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 95.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 119.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 143.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 140.6575,
              "Max": 172.4832,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.09144089,
              "Max": 12.65344,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Martin2008_400mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Martin2008_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Martin 2008 - Atazanavir monotherapy (n = 24) - Atazanavir - PO - 400 mg - Plasma - agg. (n=24)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Martin 2008 - Atazanavir monotherapy (n = 24) - Atazanavir - PO - 400 mg - Plasma - agg. (n=24)|Time",
              "Y": "Martin 2008 - Atazanavir monotherapy (n = 24) - Atazanavir - PO - 400 mg - Plasma - agg. (n=24)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Atazanavir_final\nMartin2008_400mg\n2019-07-29 16:09"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    },
    {
      "Name": "Zhu2011_400mg",
      "Model": "4Comp",
      "ObservedData": [
        "Zhu 2011 - Treatment A: Atazanavir 400 mg QPM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)",
        "Zhu 2011 - Treatment B: Atazanavir 400 mg QAM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 124.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 124.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "Zhu2011",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "400mg_QD_6days",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "Events": [
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 0.0,
            "Unit": "h"
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 23.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 47.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 71.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 95.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "High-fat breakfast",
          "StartTime": {
            "Value": 119.5,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 118.1957,
              "Max": 145.422,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.07366858,
              "Max": 18.9237,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Zhu2011_400mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Zhu2011_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Zhu 2011 - Treatment B: Atazanavir 400 mg QAM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Zhu 2011 - Treatment B: Atazanavir 400 mg QAM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)|Time",
              "Y": "Zhu 2011 - Treatment B: Atazanavir 400 mg QAM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "Zhu 2011 - Treatment A: Atazanavir 400 mg QPM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Zhu 2011 - Treatment A: Atazanavir 400 mg QPM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)|Time",
              "Y": "Zhu 2011 - Treatment A: Atazanavir 400 mg QPM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Atazanavir_final\nZhu2011_400mg\n2019-07-29 13:46"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    },
    {
      "Name": "FDA-ClinPharmReview_AI424-040_200mg",
      "Model": "4Comp",
      "ObservedData": [
        "ClinPharmReview, AI424-040, p. 64 - 200 mg - Atazanavir - PO - 200 mg - Plasma - agg. (n=20)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 96.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 96.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 100.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 100.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|200mg_QD_5days|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|200mg_QD_5days|Reyataz capsule|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|200mg_QD_5days|Reyataz capsule|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|200mg_QD_5days|Reyataz capsule|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|200mg_QD_5days|Reyataz capsule|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "WhiteAmericanMale",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "200mg_QD_5days",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "Events": [
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 0.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 23.92,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 47.92,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 71.92,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 95.92,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 95.31647,
              "Max": 121.3004,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.02714546,
              "Max": 3.286363,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "FDA-ClinPharmReview_AI424-040_200mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "FDA-ClinPharmReview_AI424-040_200mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "ClinPharmReview, AI424-040, p. 64 - 200 mg - Atazanavir - PO - 200 mg - Plasma - agg. (n=20)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "ClinPharmReview, AI424-040, p. 64 - 200 mg - Atazanavir - PO - 200 mg - Plasma - agg. (n=20)|Time",
              "Y": "ClinPharmReview, AI424-040, p. 64 - 200 mg - Atazanavir - PO - 200 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Atazanavir_final\nFDA-ClinPharmReview_AI424-040_200mg\n2019-07-29 13:41"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    },
    {
      "Name": "FDA-ClinPharmReview_AI424-040_400mg",
      "Model": "4Comp",
      "ObservedData": [
        "ClinPharmReview, AI424-040, p. 64 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=20)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 96.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 96.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 100.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 100.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|400mg_QD_5days|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_5days|Reyataz capsule|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_5days|Reyataz capsule|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_5days|Reyataz capsule|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_5days|Reyataz capsule|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "WhiteAmericanMale",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "400mg_QD_5days",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "Events": [
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 0.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 23.92,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 47.92,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 71.92,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 95.92,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 94.16508,
              "Max": 127.4921,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.07979063,
              "Max": 7.79619,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "FDA-ClinPharmReview_AI424-040_400mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "FDA-ClinPharmReview_AI424-040_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "ClinPharmReview, AI424-040, p. 64 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=20)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "ClinPharmReview, AI424-040, p. 64 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=20)|Time",
              "Y": "ClinPharmReview, AI424-040, p. 64 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Atazanavir_final\nFDA-ClinPharmReview_AI424-040_400mg\n2019-07-29 16:07"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    },
    {
      "Name": "FDA-ClinPharmReview_AI424-040_800mg",
      "Model": "4Comp",
      "ObservedData": [
        "ClinPharmReview, AI424-040, p. 64 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=20)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 96.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 96.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 100.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 100.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|800mg_QD_5days|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|800mg_QD_5days|Reyataz capsule|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|800mg_QD_5days|Reyataz capsule|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|800mg_QD_5days|Reyataz capsule|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|800mg_QD_5days|Reyataz capsule|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "WhiteAmericanMale",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "800mg_QD_5days",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "Events": [
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 0.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 23.92,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 47.92,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 71.92,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 95.92,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 96.28777,
              "Max": 120.3742,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 1.129912,
              "Max": 18.06746,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "FDA-ClinPharmReview_AI424-040_800mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "FDA-ClinPharmReview_AI424-040_800mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "ClinPharmReview, AI424-040, p. 64 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=20)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "ClinPharmReview, AI424-040, p. 64 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=20)|Time",
              "Y": "ClinPharmReview, AI424-040, p. 64 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Atazanavir_final\nFDA-ClinPharmReview_AI424-040_800mg\n2019-07-29 16:08"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    },
    {
      "Name": "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales",
      "Model": "4Comp",
      "ObservedData": [
        "ClinPharmReview, AI424-014, p. 77 - Young Females - Atazanavir - PO - 400 mg - Plasma - agg. (n=14)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|400mg_SD|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "WhiteAmericanFemale",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "400mg_SD",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "Events": [
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 0.0,
            "Unit": "h"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "ClinPharmReview, AI424-014, p. 77 - Young Females - Atazanavir - PO - 400 mg - Plasma - agg. (n=14)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "ClinPharmReview, AI424-014, p. 77 - Young Females - Atazanavir - PO - 400 mg - Plasma - agg. (n=14)|Time",
              "Y": "ClinPharmReview, AI424-014, p. 77 - Young Females - Atazanavir - PO - 400 mg - Plasma - agg. (n=14)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "None",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Atazanavir_final\nFDA-ClinPharmReview_AI424-014_400mg_YoungFemales\n2019-07-29 17:46"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    },
    {
      "Name": "FDA-ClinPharmReview_AI424-014_400mg_YoungMales",
      "Model": "4Comp",
      "ObservedData": [
        "ClinPharmReview, AI424-029, p. 47 - Urinary radioactivity - Atazanavir - PO - 400  - Urine - agg. (n=12)",
        "ClinPharmReview, AI424-014, p. 77 - Young Males - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 168.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|400mg_SD|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Events|Light meal|Light meal_1|Start time",
          "Value": 0.0,
          "Unit": "h",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
        "Organism|Kidney|Urine|Atazanavir|Fraction excreted to urine"
      ],
      "Individual": "WhiteAmericanMale",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "400mg_SD",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "Events": [
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 0.0,
            "Unit": "h"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": -4.853333,
              "Max": 28.46667,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.01722365,
              "Max": 3.721563,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            },
            {
              "Unit": "",
              "Dimension": "Fraction",
              "Type": "Y2",
              "GridLines": false,
              "Visible": true,
              "Min": 9.489025E-05,
              "Max": 0.02050323,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Dash",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "FDA-ClinPharmReview_AI424-014_400mg_YoungMales-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "FDA-ClinPharmReview_AI424-014_400mg_YoungMales-Atazanavir-Kidney-Urine-Fraction excreted to urine",
              "X": "Time",
              "Y": "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Organism|Kidney|Urine|Atazanavir|Fraction excreted to urine",
              "CurveOptions": {
                "yAxisType": "Y2",
                "Color": "#ECD33A",
                "LegendIndex": 3,
                "LineStyle": "Dash"
              }
            },
            {
              "Name": "ClinPharmReview, AI424-029, p. 47 - Urinary radioactivity - Atazanavir - PO - 400  - Urine - agg. (n=12)-Atazanavir-Kidney-Urine-ArithmeticMean",
              "X": "ClinPharmReview, AI424-029, p. 47 - Urinary radioactivity - Atazanavir - PO - 400  - Urine - agg. (n=12)|Time",
              "Y": "ClinPharmReview, AI424-029, p. 47 - Urinary radioactivity - Atazanavir - PO - 400  - Urine - agg. (n=12)|ObservedData|Kidney|Urine|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "yAxisType": "Y2",
                "Color": "#ECD33A",
                "LegendIndex": 6,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "ClinPharmReview, AI424-014, p. 77 - Young Males - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "ClinPharmReview, AI424-014, p. 77 - Young Males - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)|Time",
              "Y": "ClinPharmReview, AI424-014, p. 77 - Young Males - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 5,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "None",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Atazanavir_final\nFDA-ClinPharmReview_AI424-014_400mg_YoungMales\n2019-07-29 17:46"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    },
    {
      "Name": "Zhu2010_300mg_Atazanavir",
      "Model": "4Comp",
      "ObservedData": [
        "Zhu 2010 - Atazanvir 300 mg twice daily - Atazanavir - PO - 300 mg - Plasma - agg. (n=22)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 108.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 264.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 264.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 269.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 269.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 288.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|300mg_BID_7days_at120h|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID_7days_at120h|Reyataz capsule|Application_10|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID_7days_at120h|Reyataz capsule|Application_11|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID_7days_at120h|Reyataz capsule|Application_12|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID_7days_at120h|Reyataz capsule|Application_13|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID_7days_at120h|Reyataz capsule|Application_14|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID_7days_at120h|Reyataz capsule|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID_7days_at120h|Reyataz capsule|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID_7days_at120h|Reyataz capsule|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID_7days_at120h|Reyataz capsule|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID_7days_at120h|Reyataz capsule|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID_7days_at120h|Reyataz capsule|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID_7days_at120h|Reyataz capsule|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID_7days_at120h|Reyataz capsule|Application_9|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "Zhu2010",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "300mg_BID_7days_at120h",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "Events": [
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 108.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 120.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 132.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 144.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 156.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 168.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 180.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 192.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 204.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 216.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 228.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 240.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 252.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 264.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 262.7631,
              "Max": 281.7994,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "ng/ml",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 764.1708,
              "Max": 8061.239,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Zhu2010_300mg_Atazanavir-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Zhu2010_300mg_Atazanavir|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Zhu 2010 - Atazanvir 300 mg twice daily - Atazanavir - PO - 300 mg - Plasma - agg. (n=22)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Zhu 2010 - Atazanvir 300 mg twice daily - Atazanavir - PO - 300 mg - Plasma - agg. (n=22)|Time",
              "Y": "Zhu 2010 - Atazanvir 300 mg twice daily - Atazanavir - PO - 300 mg - Plasma - agg. (n=22)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Atazanavir_final\nZhu2010_300mg_Atazanavir\n2019-07-29 15:28"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    },
    {
      "Name": "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects",
      "Model": "4Comp",
      "ObservedData": [
        "ClinPharmReview, AI424-015, p. 81 - Normal subjects - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 72.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|400mg_SD|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Events|Light meal|Light meal_1|Start time",
          "Value": 0.0,
          "Unit": "h",
          "ValueOrigin": {
            "Source": "Unknown"
          }
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "WhiteAmericanMale",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "400mg_SD",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "Events": [
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 0.0,
            "Unit": "h"
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            },
            {
              "Unit": "",
              "Type": "Y2",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Dash",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "ClinPharmReview, AI424-015, p. 81 - Normal subjects - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "ClinPharmReview, AI424-015, p. 81 - Normal subjects - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)|Time",
              "Y": "ClinPharmReview, AI424-015, p. 81 - Normal subjects - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "None",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Atazanavir_final\nFDA-ClinPharmReview_AI424-015_400mg_NormalSubjects\n2019-07-29 17:50"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    },
    {
      "Name": "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA",
      "Model": "4Comp",
      "ObservedData": [
        "ClinPharmReview, AI424-004, p. 94 - Treatment A - Atazanavir - PO - 400 mg - Plasma - agg. (n=32)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h"
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 2.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 24.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|400mg_SD|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "WhiteAmericanMale",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "400mg_SD",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            },
            {
              "Unit": "",
              "Type": "Y2",
              "GridLines": false,
              "Visible": true,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Dash",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "ClinPharmReview, AI424-004, p. 94 - Treatment A - Atazanavir - PO - 400 mg - Plasma - agg. (n=32)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "ClinPharmReview, AI424-004, p. 94 - Treatment A - Atazanavir - PO - 400 mg - Plasma - agg. (n=32)|Time",
              "Y": "ClinPharmReview, AI424-004, p. 94 - Treatment A - Atazanavir - PO - 400 mg - Plasma - agg. (n=32)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "Settings": {
            "SideMarginsEnabled": true,
            "LegendPosition": "None",
            "BackColor": "#FFFFFF",
            "DiagramBackColor": "#FFFFFF"
          },
          "OriginText": "Atazanavir_final\nFDA-ClinPharmReview_AI424-004_400mg_TreatmentA\n2019-07-29 17:46"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    },
    {
      "Name": "Acosta2007_300mg",
      "Model": "4Comp",
      "ObservedData": [
        "Acosta 2007 - Period 1 - Atazanavir - PO - 300 mg - Plasma - agg. (n=10)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 168.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 168.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 172.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 172.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 180.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|300mg_BID|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID|Reyataz capsule|Application_10|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID|Reyataz capsule|Application_11|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID|Reyataz capsule|Application_12|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID|Reyataz capsule|Application_13|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID|Reyataz capsule|Application_14|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID|Reyataz capsule|Application_15|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID|Reyataz capsule|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID|Reyataz capsule|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID|Reyataz capsule|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID|Reyataz capsule|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID|Reyataz capsule|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID|Reyataz capsule|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID|Reyataz capsule|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_BID|Reyataz capsule|Application_9|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "Acosta2007",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "300mg_BID",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "Events": [
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 0.0,
            "Unit": "h"
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 12.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 24.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 36.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 48.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 60.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 72.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 84.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 96.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 108.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 120.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 132.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 144.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 156.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 168.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 180.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 192.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 204.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 216.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 228.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 240.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 252.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 264.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 276.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 288.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 300.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 312.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 162.7884,
              "Max": 186.0845,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.1413618,
              "Max": 12.44193,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "Acosta2007_300mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "Acosta2007_300mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "Acosta 2007 - Period 1 - Atazanavir - PO - 300 mg - Plasma - agg. (n=10)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "Acosta 2007 - Period 1 - Atazanavir - PO - 300 mg - Plasma - agg. (n=10)|Time",
              "Y": "Acosta 2007 - Period 1 - Atazanavir - PO - 300 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Atazanavir_final\nAcosta2007_300mg\n2019-07-30 09:49"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    },
    {
      "Name": "FDA-ClinPharmReview_AI424-028_200mg",
      "Model": "4Comp",
      "ObservedData": [
        "ClinPharmReview, AI424-028, p. 128 - A-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)",
        "ClinPharmReview, AI424-028, p. 128 - B-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 124.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 124.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|200mg_QD_6days|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|200mg_QD_6days|Reyataz capsule|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|200mg_QD_6days|Reyataz capsule|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|200mg_QD_6days|Reyataz capsule|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|200mg_QD_6days|Reyataz capsule|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|200mg_QD_6days|Reyataz capsule|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "WhiteAmericanMale",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "200mg_QD_6days",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "Events": [
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 0.0,
            "Unit": "h"
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 24.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 48.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 72.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 96.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 120.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 118.5373,
              "Max": 149.4788,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.02778691,
              "Max": 3.401563,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "FDA-ClinPharmReview_AI424-028_200mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "FDA-ClinPharmReview_AI424-028_200mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "ClinPharmReview, AI424-028, p. 128 - A-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "ClinPharmReview, AI424-028, p. 128 - A-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)|Time",
              "Y": "ClinPharmReview, AI424-028, p. 128 - A-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "ClinPharmReview, AI424-028, p. 128 - B-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "ClinPharmReview, AI424-028, p. 128 - B-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)|Time",
              "Y": "ClinPharmReview, AI424-028, p. 128 - B-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Atazanavir_final\nFDA-ClinPharmReview_AI424-028_200mg\n2019-07-29 15:52"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    },
    {
      "Name": "FDA-ClinPharmReview_AI424-028_400mg",
      "Model": "4Comp",
      "ObservedData": [
        "ClinPharmReview, AI424-028, p. 128 - C-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)",
        "ClinPharmReview, AI424-028, p. 128 - D-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 124.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 124.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 144.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "WhiteAmericanMale",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "400mg_QD_6days",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "Events": [
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 0.0,
            "Unit": "h"
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 24.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 48.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 72.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 96.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 120.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 118.2216,
              "Max": 146.6373,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.1914686,
              "Max": 9.440516,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "FDA-ClinPharmReview_AI424-028_400mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "FDA-ClinPharmReview_AI424-028_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "ClinPharmReview, AI424-028, p. 128 - D-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "ClinPharmReview, AI424-028, p. 128 - D-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)|Time",
              "Y": "ClinPharmReview, AI424-028, p. 128 - D-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#008000",
                "LegendIndex": 3,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            },
            {
              "Name": "ClinPharmReview, AI424-028, p. 128 - C-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "ClinPharmReview, AI424-028, p. 128 - C-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)|Time",
              "Y": "ClinPharmReview, AI424-028, p. 128 - C-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Atazanavir_final\nFDA-ClinPharmReview_AI424-028_400mg\n2019-07-29 13:41"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    },
    {
      "Name": "FDA-ClinPharmReview_AI424-056_300mg",
      "Model": "4Comp",
      "ObservedData": [
        "ClinPharmReview, AI424-056, p. 134 - Atazanavir without ritonavir, Day 10 - Atazanavir - PO - 300 mg - Plasma - agg. (n=30)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 216.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 216.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 220.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 220.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 240.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|300mg_QD_10days|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_QD_10days|Reyataz capsule|Application_10|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_QD_10days|Reyataz capsule|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_QD_10days|Reyataz capsule|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_QD_10days|Reyataz capsule|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_QD_10days|Reyataz capsule|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_QD_10days|Reyataz capsule|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_QD_10days|Reyataz capsule|Application_7|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_QD_10days|Reyataz capsule|Application_8|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|300mg_QD_10days|Reyataz capsule|Application_9|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "WhiteAmericanMale",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "300mg_QD_10days",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "Events": [
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 0.0,
            "Unit": "h"
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 24.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 48.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 72.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 96.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 120.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 144.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 168.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 192.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 216.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 213.5932,
              "Max": 240.7027,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.002471656,
              "Max": 9.924288,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "FDA-ClinPharmReview_AI424-056_300mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "FDA-ClinPharmReview_AI424-056_300mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "ClinPharmReview, AI424-056, p. 134 - Atazanavir without ritonavir, Day 10 - Atazanavir - PO - 300 mg - Plasma - agg. (n=30)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "ClinPharmReview, AI424-056, p. 134 - Atazanavir without ritonavir, Day 10 - Atazanavir - PO - 300 mg - Plasma - agg. (n=30)|Time",
              "Y": "ClinPharmReview, AI424-056, p. 134 - Atazanavir without ritonavir, Day 10 - Atazanavir - PO - 300 mg - Plasma - agg. (n=30)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Atazanavir_final\nFDA-ClinPharmReview_AI424-056_300mg\n2019-07-29 13:43"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    },
    {
      "Name": "FDA-ClinPharmReview_AI424-076_400mg",
      "Model": "4Comp",
      "ObservedData": [
        "ClinPharmReview, AI424-076, p. 178 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 124.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 124.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 192.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|400mg_QD_6days|Reyataz capsule|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "WhiteAmericanMale",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "400mg_QD_6days",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "Events": [
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 0.0,
            "Unit": "h"
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 24.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 48.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 72.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 96.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 120.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 114.2347,
              "Max": 198.3917,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.005789065,
              "Max": 9.533953,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "FDA-ClinPharmReview_AI424-076_400mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "FDA-ClinPharmReview_AI424-076_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "ClinPharmReview, AI424-076, p. 178 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "ClinPharmReview, AI424-076, p. 178 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)|Time",
              "Y": "ClinPharmReview, AI424-076, p. 178 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Atazanavir_final\nFDA-ClinPharmReview_AI424-076_400mg\n2019-07-29 13:44"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    },
    {
      "Name": "FDA-ClinPharmReview_AI424-076_800mg",
      "Model": "4Comp",
      "ObservedData": [
        "ClinPharmReview, AI424-076, p. 178 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=66)"
      ],
      "Solver": {},
      "OutputSchema": [
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 0.0,
              "Unit": "h"
            },
            {
              "Name": "End time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 120.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 124.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 20.0,
              "Unit": "pts/h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            }
          ]
        },
        {
          "Parameters": [
            {
              "Name": "Start time",
              "Value": 124.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "End time",
              "Value": 192.0,
              "Unit": "h",
              "ValueOrigin": {
                "Source": "Unknown"
              }
            },
            {
              "Name": "Resolution",
              "Value": 4.0,
              "Unit": "pts/h"
            }
          ]
        }
      ],
      "Parameters": [
        {
          "Path": "Applications|800mg_QD_6days|Reyataz capsule|Application_1|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|800mg_QD_6days|Reyataz capsule|Application_2|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|800mg_QD_6days|Reyataz capsule|Application_3|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|800mg_QD_6days|Reyataz capsule|Application_4|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|800mg_QD_6days|Reyataz capsule|Application_5|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        },
        {
          "Path": "Applications|800mg_QD_6days|Reyataz capsule|Application_6|ProtocolSchemaItem|Volume of water/body weight",
          "Value": 3.5,
          "Unit": "ml/kg"
        }
      ],
      "OutputSelections": [
        "Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)"
      ],
      "Individual": "WhiteAmericanMale",
      "Compounds": [
        {
          "Name": "Atazanavir",
          "CalculationMethods": [
            "Cellular partition coefficient method - Rodgers and Rowland",
            "Cellular permeability - PK-Sim Standard"
          ],
          "Alternatives": [
            {
              "AlternativeName": "Optimized",
              "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY"
            }
          ],
          "Processes": [
            {
              "Name": "CYP3A4-Optimized",
              "MoleculeName": "CYP3A4"
            },
            {
              "Name": "Glomerular Filtration-Clinical Pharmacology Review"
            }
          ],
          "Protocol": {
            "Name": "800mg_QD_6days",
            "Formulations": [
              {
                "Name": "Reyataz capsule",
                "Key": "Formulation"
              }
            ]
          }
        }
      ],
      "Events": [
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 0.0,
            "Unit": "h"
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 24.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 48.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 72.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 96.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        },
        {
          "Name": "Light meal",
          "StartTime": {
            "Value": 120.0,
            "Unit": "h",
            "ValueOrigin": {
              "Source": "Unknown"
            }
          }
        }
      ],
      "HasResults": true,
      "IndividualAnalyses": [
        {
          "Axes": [
            {
              "Unit": "h",
              "Dimension": "Time",
              "Type": "X",
              "GridLines": false,
              "Visible": true,
              "Min": 112.9409,
              "Max": 197.0133,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "None",
              "Scaling": "Linear",
              "NumberMode": "Normal"
            },
            {
              "Unit": "µmol/l",
              "Dimension": "Concentration (molar)",
              "Type": "Y",
              "GridLines": false,
              "Visible": true,
              "Min": 0.01369614,
              "Max": 47.78296,
              "DefaultColor": "#FFFFFF",
              "DefaultLineStyle": "Solid",
              "Scaling": "Log",
              "NumberMode": "Normal"
            }
          ],
          "Curves": [
            {
              "Name": "FDA-ClinPharmReview_AI424-076_800mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
              "X": "Time",
              "Y": "FDA-ClinPharmReview_AI424-076_800mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
              "CurveOptions": {
                "Color": "#FF0000",
                "LegendIndex": 1
              }
            },
            {
              "Name": "ClinPharmReview, AI424-076, p. 178 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=66)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
              "X": "ClinPharmReview, AI424-076, p. 178 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=66)|Time",
              "Y": "ClinPharmReview, AI424-076, p. 178 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=66)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
              "CurveOptions": {
                "Color": "#0000FF",
                "LegendIndex": 2,
                "LineStyle": "None",
                "Symbol": "Circle"
              }
            }
          ],
          "Name": "Time Profile Analysis",
          "OriginText": "Atazanavir_final\nFDA-ClinPharmReview_AI424-076_800mg\n2019-07-29 13:44"
        }
      ],
      "Interactions": [
        {
          "Name": "CYP3A4-Perloff2005",
          "MoleculeName": "CYP3A4",
          "CompoundName": "Atazanavir"
        }
      ]
    }
  ],
  "ParameterIdentifications": [
    {
      "Name": "SingleDose_withoutMBI",
      "Simulations": [
        "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA",
        "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales",
        "FDA-ClinPharmReview_AI424-014_400mg_YoungMales",
        "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects"
      ],
      "Configuration": {
        "LLOQMode": "SimulationOutputAsObservedDataLLOQ",
        "RemoveLLOQMode": "Never",
        "CalculateJacobian": true,
        "Algorithm": {
          "Name": "Levenberg - Marquardt (MPFit)",
          "Properties": [
            {
              "Name": "ftol",
              "Value": 0.001
            },
            {
              "Name": "xtol",
              "Value": 1E-06
            },
            {
              "Name": "gtol",
              "Value": 1E-10
            },
            {
              "Name": "stepfactor",
              "Value": 100.0
            },
            {
              "Name": "maxiter",
              "Value": 200
            },
            {
              "Name": "maxfev",
              "Value": 0
            },
            {
              "Name": "epsfcn",
              "Value": 1E-09
            }
          ]
        }
      },
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "ClinPharmReview, AI424-004, p. 94 - Treatment A - Atazanavir - PO - 400 mg - Plasma - agg. (n=32)"
        },
        {
          "Scaling": "Log",
          "Path": "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "ClinPharmReview, AI424-014, p. 77 - Young Females - Atazanavir - PO - 400 mg - Plasma - agg. (n=14)"
        },
        {
          "Scaling": "Log",
          "Path": "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "ClinPharmReview, AI424-014, p. 77 - Young Males - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)"
        },
        {
          "Scaling": "Linear",
          "Weight": 20.0,
          "Path": "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Organism|Kidney|Urine|Atazanavir|Fraction excreted to urine",
          "ObservedData": "ClinPharmReview, AI424-029, p. 47 - Urinary radioactivity - Atazanavir - PO - 400  - Urine - agg. (n=12)"
        },
        {
          "Scaling": "Log",
          "Path": "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "ClinPharmReview, AI424-015, p. 81 - Normal subjects - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)"
        }
      ],
      "IdentificationParameters": [
        {
          "Name": "Dissolution shape",
          "Scaling": "Log",
          "LinkedParameters": [
            "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA|Applications|400mg_SD|Reyataz capsule|Dissolution shape",
            "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales|Applications|400mg_SD|Reyataz capsule|Dissolution shape",
            "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Applications|400mg_SD|Reyataz capsule|Dissolution shape",
            "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects|Applications|400mg_SD|Reyataz capsule|Dissolution shape"
          ],
          "Parameters": [
            {
              "Name": "Start value",
              "Value": 0.92
            },
            {
              "Name": "MinValue",
              "Value": 0.1
            },
            {
              "Name": "MaxValue",
              "Value": 10.0
            }
          ]
        },
        {
          "Name": "Dissolution time (50% dissolved)",
          "Scaling": "Log",
          "LinkedParameters": [
            "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA|Applications|400mg_SD|Reyataz capsule|Dissolution time (50% dissolved)",
            "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales|Applications|400mg_SD|Reyataz capsule|Dissolution time (50% dissolved)",
            "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Applications|400mg_SD|Reyataz capsule|Dissolution time (50% dissolved)",
            "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects|Applications|400mg_SD|Reyataz capsule|Dissolution time (50% dissolved)"
          ],
          "Parameters": [
            {
              "Name": "Start value",
              "Value": 60.0,
              "Unit": "min"
            },
            {
              "Name": "MinValue",
              "Value": 0.1,
              "Unit": "min"
            },
            {
              "Name": "MaxValue",
              "Value": 1000.0,
              "Unit": "min"
            }
          ]
        },
        {
          "Name": "Specific intestinal permeability (transcellular)",
          "Scaling": "Log",
          "LinkedParameters": [
            "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA|Atazanavir|Specific intestinal permeability (transcellular)",
            "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales|Atazanavir|Specific intestinal permeability (transcellular)",
            "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Atazanavir|Specific intestinal permeability (transcellular)",
            "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects|Atazanavir|Specific intestinal permeability (transcellular)"
          ],
          "Parameters": [
            {
              "Name": "Start value",
              "Value": 3.2106E-07,
              "Unit": "cm/min"
            },
            {
              "Name": "MinValue",
              "Value": 1E-10,
              "Unit": "cm/min"
            },
            {
              "Name": "MaxValue",
              "Value": 0.001,
              "Unit": "cm/min"
            }
          ]
        },
        {
          "Name": "GFR fraction",
          "Scaling": "Log",
          "LinkedParameters": [
            "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction"
          ],
          "Parameters": [
            {
              "Name": "Start value",
              "Value": 1.0
            },
            {
              "Name": "MinValue",
              "Value": 0.1
            },
            {
              "Name": "MaxValue",
              "Value": 10.0
            }
          ]
        },
        {
          "Name": "CLspec/[Enzyme]",
          "Scaling": "Log",
          "LinkedParameters": [
            "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA|Atazanavir-CYP3A4-Optimized|CLspec/[Enzyme]",
            "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales|Atazanavir-CYP3A4-Optimized|CLspec/[Enzyme]",
            "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Atazanavir-CYP3A4-Optimized|CLspec/[Enzyme]",
            "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects|Atazanavir-CYP3A4-Optimized|CLspec/[Enzyme]"
          ],
          "Parameters": [
            {
              "Name": "Start value",
              "Value": 1.0,
              "Unit": "l/µmol/min"
            },
            {
              "Name": "MinValue",
              "Value": 0.01,
              "Unit": "l/µmol/min"
            },
            {
              "Name": "MaxValue",
              "Value": 10.0,
              "Unit": "l/µmol/min"
            }
          ]
        },
        {
          "Name": "kinact",
          "Scaling": "Linear",
          "IsFixed": true,
          "LinkedParameters": [
            "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA|Atazanavir|CYP3A4-Perloff2005|kinact",
            "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales|Atazanavir|CYP3A4-Perloff2005|kinact",
            "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Atazanavir|CYP3A4-Perloff2005|kinact",
            "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects|Atazanavir|CYP3A4-Perloff2005|kinact"
          ],
          "Parameters": [
            {
              "Name": "Start value",
              "Value": 0.0,
              "Unit": "1/min"
            },
            {
              "Name": "MinValue",
              "Value": 0.0,
              "Unit": "1/min"
            },
            {
              "Name": "MaxValue",
              "Value": 0.0894034784,
              "Unit": "1/min"
            }
          ]
        }
      ],
      "Analyses": [
        {
          "Name": "Time Profile",
          "Type": "ParameterIdentificationTimeProfileChart",
          "Chart": {
            "Axes": [
              {
                "Unit": "h",
                "Dimension": "Time",
                "Type": "X",
                "GridLines": false,
                "Visible": true,
                "DefaultColor": "#FFFFFF",
                "DefaultLineStyle": "None",
                "Scaling": "Linear",
                "NumberMode": "Normal"
              },
              {
                "Unit": "mg/l",
                "Dimension": "Concentration (mass)",
                "Type": "Y",
                "GridLines": false,
                "Visible": true,
                "DefaultColor": "#FFFFFF",
                "DefaultLineStyle": "Solid",
                "Scaling": "Log",
                "NumberMode": "Normal"
              },
              {
                "Unit": "",
                "Dimension": "Fraction",
                "Type": "Y2",
                "GridLines": false,
                "Visible": true,
                "DefaultColor": "#FFFFFF",
                "DefaultLineStyle": "Dash",
                "Scaling": "Linear",
                "NumberMode": "Normal"
              }
            ],
            "Curves": [
              {
                "Name": "ClinPharmReview, AI424-004, p. 94 - Treatment A - Atazanavir - PO - 400 mg - Plasma - agg. (n=32)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "ClinPharmReview, AI424-004, p. 94 - Treatment A - Atazanavir - PO - 400 mg - Plasma - agg. (n=32)|Time",
                "Y": "ClinPharmReview, AI424-004, p. 94 - Treatment A - Atazanavir - PO - 400 mg - Plasma - agg. (n=32)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#FF0000",
                  "LegendIndex": 1,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-014, p. 77 - Young Females - Atazanavir - PO - 400 mg - Plasma - agg. (n=14)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "ClinPharmReview, AI424-014, p. 77 - Young Females - Atazanavir - PO - 400 mg - Plasma - agg. (n=14)|Time",
                "Y": "ClinPharmReview, AI424-014, p. 77 - Young Females - Atazanavir - PO - 400 mg - Plasma - agg. (n=14)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#0000FF",
                  "LegendIndex": 2,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-014, p. 77 - Young Males - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "ClinPharmReview, AI424-014, p. 77 - Young Males - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)|Time",
                "Y": "ClinPharmReview, AI424-014, p. 77 - Young Males - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#008000",
                  "LegendIndex": 3,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-029, p. 47 - Urinary radioactivity - Atazanavir - PO - 400  - Urine - agg. (n=12)-Atazanavir-Kidney-Urine-ArithmeticMean",
                "X": "ClinPharmReview, AI424-029, p. 47 - Urinary radioactivity - Atazanavir - PO - 400  - Urine - agg. (n=12)|Time",
                "Y": "ClinPharmReview, AI424-029, p. 47 - Urinary radioactivity - Atazanavir - PO - 400  - Urine - agg. (n=12)|ObservedData|Kidney|Urine|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "yAxisType": "Y2",
                  "VisibleInLegend": false,
                  "Color": "#FF00FF",
                  "LegendIndex": 4,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-015, p. 81 - Normal subjects - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "ClinPharmReview, AI424-015, p. 81 - Normal subjects - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)|Time",
                "Y": "ClinPharmReview, AI424-015, p. 81 - Normal subjects - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#FF8000",
                  "LegendIndex": 5,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#FF0000",
                  "LegendIndex": 6
                }
              },
              {
                "Name": "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#0000FF",
                  "LegendIndex": 7
                }
              },
              {
                "Name": "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#FF8000",
                  "LegendIndex": 8
                }
              },
              {
                "Name": "FDA-ClinPharmReview_AI424-014_400mg_YoungMales-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#008000",
                  "LegendIndex": 9
                }
              },
              {
                "Name": "FDA-ClinPharmReview_AI424-014_400mg_YoungMales-Atazanavir-Kidney-Urine-Fraction excreted to urine",
                "X": "Time",
                "Y": "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Organism|Kidney|Urine|Atazanavir|Fraction excreted to urine",
                "CurveOptions": {
                  "yAxisType": "Y2",
                  "Color": "#FF00FF",
                  "LegendIndex": 10,
                  "LineStyle": "Dash"
                }
              }
            ],
            "Name": "Time Profile",
            "Settings": {
              "SideMarginsEnabled": true,
              "LegendPosition": "Bottom",
              "BackColor": "#FFFFFF",
              "DiagramBackColor": "#FFFFFF"
            }
          }
        }
      ]
    },
    {
      "Name": "Single+MultipleDose_withMBI",
      "Simulations": [
        "Acosta2007_300mg",
        "Agarwala2003_400mg",
        "Agarwala2005a_400mg",
        "Agarwala2005b_400mg",
        "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA",
        "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales",
        "FDA-ClinPharmReview_AI424-014_400mg_YoungMales",
        "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects",
        "FDA-ClinPharmReview_AI424-028_200mg",
        "FDA-ClinPharmReview_AI424-028_400mg",
        "FDA-ClinPharmReview_AI424-040_200mg",
        "FDA-ClinPharmReview_AI424-040_400mg",
        "FDA-ClinPharmReview_AI424-040_800mg",
        "FDA-ClinPharmReview_AI424-056_300mg",
        "FDA-ClinPharmReview_AI424-076_400mg",
        "FDA-ClinPharmReview_AI424-076_800mg",
        "Martin2008_400mg",
        "Zhu2010_300mg_Atazanavir",
        "Zhu2011_400mg"
      ],
      "Configuration": {
        "LLOQMode": "SimulationOutputAsObservedDataLLOQ",
        "RemoveLLOQMode": "Never",
        "CalculateJacobian": true,
        "Algorithm": {
          "Name": "Levenberg - Marquardt (MPFit)",
          "Properties": [
            {
              "Name": "ftol",
              "Value": 0.001
            },
            {
              "Name": "xtol",
              "Value": 1E-06
            },
            {
              "Name": "gtol",
              "Value": 1E-10
            },
            {
              "Name": "stepfactor",
              "Value": 100.0
            },
            {
              "Name": "maxiter",
              "Value": 200
            },
            {
              "Name": "maxfev",
              "Value": 0
            },
            {
              "Name": "epsfcn",
              "Value": 1E-09
            }
          ]
        }
      },
      "OutputMappings": [
        {
          "Scaling": "Log",
          "Path": "Acosta2007_300mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Acosta 2007 - Period 1 - Atazanavir - PO - 300 mg - Plasma - agg. (n=10)"
        },
        {
          "Scaling": "Log",
          "Path": "Agarwala2003_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Agarwala 2003 - Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)"
        },
        {
          "Scaling": "Log",
          "Path": "Agarwala2005a_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Agarwala 2005a - ATV 400 mg AM (N=15) - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)"
        },
        {
          "Scaling": "Log",
          "Path": "Agarwala2005b_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Agarwala 2005b - ATV 400 mg (Treatment A) - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)"
        },
        {
          "Scaling": "Log",
          "Path": "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "ClinPharmReview, AI424-004, p. 94 - Treatment A - Atazanavir - PO - 400 mg - Plasma - agg. (n=32)"
        },
        {
          "Scaling": "Log",
          "Path": "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "ClinPharmReview, AI424-014, p. 77 - Young Females - Atazanavir - PO - 400 mg - Plasma - agg. (n=14)"
        },
        {
          "Scaling": "Log",
          "Path": "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "ClinPharmReview, AI424-014, p. 77 - Young Males - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)"
        },
        {
          "Scaling": "Linear",
          "Weight": 50.0,
          "Path": "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Organism|Kidney|Urine|Atazanavir|Fraction excreted to urine",
          "ObservedData": "ClinPharmReview, AI424-029, p. 47 - Urinary radioactivity - Atazanavir - PO - 400  - Urine - agg. (n=12)"
        },
        {
          "Scaling": "Log",
          "Path": "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "ClinPharmReview, AI424-015, p. 81 - Normal subjects - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)"
        },
        {
          "Scaling": "Log",
          "Path": "FDA-ClinPharmReview_AI424-028_200mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "ClinPharmReview, AI424-028, p. 128 - A-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "FDA-ClinPharmReview_AI424-028_200mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "ClinPharmReview, AI424-028, p. 128 - B-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "FDA-ClinPharmReview_AI424-028_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "ClinPharmReview, AI424-028, p. 128 - C-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "FDA-ClinPharmReview_AI424-028_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "ClinPharmReview, AI424-028, p. 128 - D-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)"
        },
        {
          "Scaling": "Log",
          "Path": "FDA-ClinPharmReview_AI424-040_200mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "ClinPharmReview, AI424-040, p. 64 - 200 mg - Atazanavir - PO - 200 mg - Plasma - agg. (n=20)"
        },
        {
          "Scaling": "Log",
          "Path": "FDA-ClinPharmReview_AI424-040_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "ClinPharmReview, AI424-040, p. 64 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=20)"
        },
        {
          "Scaling": "Log",
          "Path": "FDA-ClinPharmReview_AI424-040_800mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "ClinPharmReview, AI424-040, p. 64 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=20)"
        },
        {
          "Scaling": "Log",
          "Path": "FDA-ClinPharmReview_AI424-056_300mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "ClinPharmReview, AI424-056, p. 134 - Atazanavir without ritonavir, Day 10 - Atazanavir - PO - 300 mg - Plasma - agg. (n=30)"
        },
        {
          "Scaling": "Log",
          "Path": "FDA-ClinPharmReview_AI424-076_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "ClinPharmReview, AI424-076, p. 178 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)"
        },
        {
          "Scaling": "Log",
          "Path": "FDA-ClinPharmReview_AI424-076_800mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "ClinPharmReview, AI424-076, p. 178 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=66)"
        },
        {
          "Scaling": "Log",
          "Path": "Martin2008_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Martin 2008 - Atazanavir monotherapy (n = 24) - Atazanavir - PO - 400 mg - Plasma - agg. (n=24)"
        },
        {
          "Scaling": "Log",
          "Path": "Zhu2010_300mg_Atazanavir|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Zhu 2010 - Atazanvir 300 mg twice daily - Atazanavir - PO - 300 mg - Plasma - agg. (n=22)"
        },
        {
          "Scaling": "Log",
          "Path": "Zhu2011_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Zhu 2011 - Treatment A: Atazanavir 400 mg QPM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)"
        },
        {
          "Scaling": "Log",
          "Path": "Zhu2011_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
          "ObservedData": "Zhu 2011 - Treatment B: Atazanavir 400 mg QAM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)"
        }
      ],
      "IdentificationParameters": [
        {
          "Name": "GFR fraction",
          "Scaling": "Log",
          "LinkedParameters": [
            "Acosta2007_300mg|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "Agarwala2003_400mg|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "Agarwala2005a_400mg|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "Agarwala2005b_400mg|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "FDA-ClinPharmReview_AI424-028_200mg|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "FDA-ClinPharmReview_AI424-028_400mg|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "FDA-ClinPharmReview_AI424-040_200mg|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "FDA-ClinPharmReview_AI424-040_400mg|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "FDA-ClinPharmReview_AI424-040_800mg|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "FDA-ClinPharmReview_AI424-056_300mg|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "FDA-ClinPharmReview_AI424-076_400mg|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "FDA-ClinPharmReview_AI424-076_800mg|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "Martin2008_400mg|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "Zhu2010_300mg_Atazanavir|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction",
            "Zhu2011_400mg|Neighborhoods|Kidney_pls_Kidney_ur|Atazanavir|Glomerular Filtration-Clinical Pharmacology Review|GFR fraction"
          ],
          "Parameters": [
            {
              "Name": "Start value",
              "Value": 2.8547217196
            },
            {
              "Name": "MinValue",
              "Value": 0.1
            },
            {
              "Name": "MaxValue",
              "Value": 10.0
            }
          ]
        },
        {
          "Name": "K_kinact_half",
          "Scaling": "Log",
          "LinkedParameters": [
            "Acosta2007_300mg|Atazanavir|CYP3A4-Perloff2005|K_kinact_half",
            "Agarwala2003_400mg|Atazanavir|CYP3A4-Perloff2005|K_kinact_half",
            "Agarwala2005a_400mg|Atazanavir|CYP3A4-Perloff2005|K_kinact_half",
            "Agarwala2005b_400mg|Atazanavir|CYP3A4-Perloff2005|K_kinact_half",
            "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA|Atazanavir|CYP3A4-Perloff2005|K_kinact_half",
            "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales|Atazanavir|CYP3A4-Perloff2005|K_kinact_half",
            "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Atazanavir|CYP3A4-Perloff2005|K_kinact_half",
            "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects|Atazanavir|CYP3A4-Perloff2005|K_kinact_half",
            "FDA-ClinPharmReview_AI424-028_200mg|Atazanavir|CYP3A4-Perloff2005|K_kinact_half",
            "FDA-ClinPharmReview_AI424-028_400mg|Atazanavir|CYP3A4-Perloff2005|K_kinact_half",
            "FDA-ClinPharmReview_AI424-040_200mg|Atazanavir|CYP3A4-Perloff2005|K_kinact_half",
            "FDA-ClinPharmReview_AI424-040_400mg|Atazanavir|CYP3A4-Perloff2005|K_kinact_half",
            "FDA-ClinPharmReview_AI424-040_800mg|Atazanavir|CYP3A4-Perloff2005|K_kinact_half",
            "FDA-ClinPharmReview_AI424-056_300mg|Atazanavir|CYP3A4-Perloff2005|K_kinact_half",
            "FDA-ClinPharmReview_AI424-076_400mg|Atazanavir|CYP3A4-Perloff2005|K_kinact_half",
            "FDA-ClinPharmReview_AI424-076_800mg|Atazanavir|CYP3A4-Perloff2005|K_kinact_half",
            "Martin2008_400mg|Atazanavir|CYP3A4-Perloff2005|K_kinact_half",
            "Zhu2010_300mg_Atazanavir|Atazanavir|CYP3A4-Perloff2005|K_kinact_half",
            "Zhu2011_400mg|Atazanavir|CYP3A4-Perloff2005|K_kinact_half"
          ],
          "Parameters": [
            {
              "Name": "Start value",
              "Value": 1.0,
              "Unit": "µmol/l"
            },
            {
              "Name": "MinValue",
              "Value": 0.0001,
              "Unit": "µmol/l"
            },
            {
              "Name": "MaxValue",
              "Value": 10000.0,
              "Unit": "µmol/l"
            }
          ]
        },
        {
          "Name": "kinact",
          "Scaling": "Log",
          "LinkedParameters": [
            "Acosta2007_300mg|Atazanavir|CYP3A4-Perloff2005|kinact",
            "Agarwala2003_400mg|Atazanavir|CYP3A4-Perloff2005|kinact",
            "Agarwala2005a_400mg|Atazanavir|CYP3A4-Perloff2005|kinact",
            "Agarwala2005b_400mg|Atazanavir|CYP3A4-Perloff2005|kinact",
            "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA|Atazanavir|CYP3A4-Perloff2005|kinact",
            "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales|Atazanavir|CYP3A4-Perloff2005|kinact",
            "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Atazanavir|CYP3A4-Perloff2005|kinact",
            "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects|Atazanavir|CYP3A4-Perloff2005|kinact",
            "FDA-ClinPharmReview_AI424-028_200mg|Atazanavir|CYP3A4-Perloff2005|kinact",
            "FDA-ClinPharmReview_AI424-028_400mg|Atazanavir|CYP3A4-Perloff2005|kinact",
            "FDA-ClinPharmReview_AI424-040_200mg|Atazanavir|CYP3A4-Perloff2005|kinact",
            "FDA-ClinPharmReview_AI424-040_400mg|Atazanavir|CYP3A4-Perloff2005|kinact",
            "FDA-ClinPharmReview_AI424-040_800mg|Atazanavir|CYP3A4-Perloff2005|kinact",
            "FDA-ClinPharmReview_AI424-056_300mg|Atazanavir|CYP3A4-Perloff2005|kinact",
            "FDA-ClinPharmReview_AI424-076_400mg|Atazanavir|CYP3A4-Perloff2005|kinact",
            "FDA-ClinPharmReview_AI424-076_800mg|Atazanavir|CYP3A4-Perloff2005|kinact",
            "Martin2008_400mg|Atazanavir|CYP3A4-Perloff2005|kinact",
            "Zhu2010_300mg_Atazanavir|Atazanavir|CYP3A4-Perloff2005|kinact",
            "Zhu2011_400mg|Atazanavir|CYP3A4-Perloff2005|kinact"
          ],
          "Parameters": [
            {
              "Name": "Start value",
              "Value": 0.1,
              "Unit": "1/min"
            },
            {
              "Name": "MinValue",
              "Value": 1E-06,
              "Unit": "1/min"
            },
            {
              "Name": "MaxValue",
              "Value": 10.0,
              "Unit": "1/min"
            }
          ]
        }
      ],
      "Analyses": [
        {
          "Name": "Correlation Matrix",
          "Type": "ParameterIdentificationCorrelationMatrix"
        },
        {
          "Name": "Time Profile",
          "Type": "ParameterIdentificationTimeProfileChart",
          "Chart": {
            "Axes": [
              {
                "Unit": "h",
                "Dimension": "Time",
                "Type": "X",
                "GridLines": false,
                "Visible": true,
                "DefaultColor": "#FFFFFF",
                "DefaultLineStyle": "None",
                "Scaling": "Linear",
                "NumberMode": "Normal"
              },
              {
                "Unit": "µmol/l",
                "Dimension": "Concentration (mass)",
                "Type": "Y",
                "GridLines": false,
                "Visible": true,
                "DefaultColor": "#FFFFFF",
                "DefaultLineStyle": "Solid",
                "Scaling": "Log",
                "NumberMode": "Normal"
              },
              {
                "Unit": "",
                "Dimension": "Fraction",
                "Type": "Y2",
                "GridLines": false,
                "Visible": true,
                "DefaultColor": "#FFFFFF",
                "DefaultLineStyle": "Dash",
                "Scaling": "Linear",
                "NumberMode": "Normal"
              }
            ],
            "Curves": [
              {
                "Name": "Acosta 2007 - Period 1 - Atazanavir - PO - 300 mg - Plasma - agg. (n=10)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "Acosta 2007 - Period 1 - Atazanavir - PO - 300 mg - Plasma - agg. (n=10)|Time",
                "Y": "Acosta 2007 - Period 1 - Atazanavir - PO - 300 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#FF0000",
                  "LegendIndex": 1,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "Agarwala 2003 - Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "Agarwala 2003 - Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)|Time",
                "Y": "Agarwala 2003 - Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#0000FF",
                  "LegendIndex": 2,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "Agarwala 2005a - ATV 400 mg AM (N=15) - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "Agarwala 2005a - ATV 400 mg AM (N=15) - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)|Time",
                "Y": "Agarwala 2005a - ATV 400 mg AM (N=15) - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#008000",
                  "LegendIndex": 3,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "Agarwala 2005b - ATV 400 mg (Treatment A) - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "Agarwala 2005b - ATV 400 mg (Treatment A) - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)|Time",
                "Y": "Agarwala 2005b - ATV 400 mg (Treatment A) - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#FF00FF",
                  "LegendIndex": 4,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-004, p. 94 - Treatment A - Atazanavir - PO - 400 mg - Plasma - agg. (n=32)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "ClinPharmReview, AI424-004, p. 94 - Treatment A - Atazanavir - PO - 400 mg - Plasma - agg. (n=32)|Time",
                "Y": "ClinPharmReview, AI424-004, p. 94 - Treatment A - Atazanavir - PO - 400 mg - Plasma - agg. (n=32)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#FF8000",
                  "LegendIndex": 5,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-014, p. 77 - Young Females - Atazanavir - PO - 400 mg - Plasma - agg. (n=14)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "ClinPharmReview, AI424-014, p. 77 - Young Females - Atazanavir - PO - 400 mg - Plasma - agg. (n=14)|Time",
                "Y": "ClinPharmReview, AI424-014, p. 77 - Young Females - Atazanavir - PO - 400 mg - Plasma - agg. (n=14)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#00C0C0",
                  "LegendIndex": 6,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-014, p. 77 - Young Males - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "ClinPharmReview, AI424-014, p. 77 - Young Males - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)|Time",
                "Y": "ClinPharmReview, AI424-014, p. 77 - Young Males - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#C000C0",
                  "LegendIndex": 7,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-029, p. 47 - Urinary radioactivity - Atazanavir - PO - 400  - Urine - agg. (n=12)-Atazanavir-Kidney-Urine-ArithmeticMean",
                "X": "ClinPharmReview, AI424-029, p. 47 - Urinary radioactivity - Atazanavir - PO - 400  - Urine - agg. (n=12)|Time",
                "Y": "ClinPharmReview, AI424-029, p. 47 - Urinary radioactivity - Atazanavir - PO - 400  - Urine - agg. (n=12)|ObservedData|Kidney|Urine|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "yAxisType": "Y2",
                  "VisibleInLegend": false,
                  "Color": "#C04000",
                  "LegendIndex": 8,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-015, p. 81 - Normal subjects - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "ClinPharmReview, AI424-015, p. 81 - Normal subjects - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)|Time",
                "Y": "ClinPharmReview, AI424-015, p. 81 - Normal subjects - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#00FF00",
                  "LegendIndex": 9,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-028, p. 128 - A-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "ClinPharmReview, AI424-028, p. 128 - A-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)|Time",
                "Y": "ClinPharmReview, AI424-028, p. 128 - A-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#808080",
                  "LegendIndex": 10,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-028, p. 128 - B-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "ClinPharmReview, AI424-028, p. 128 - B-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)|Time",
                "Y": "ClinPharmReview, AI424-028, p. 128 - B-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#808080",
                  "LegendIndex": 11,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-028, p. 128 - C-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "ClinPharmReview, AI424-028, p. 128 - C-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)|Time",
                "Y": "ClinPharmReview, AI424-028, p. 128 - C-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#C0C000",
                  "LegendIndex": 12,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-028, p. 128 - D-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "ClinPharmReview, AI424-028, p. 128 - D-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)|Time",
                "Y": "ClinPharmReview, AI424-028, p. 128 - D-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#C0C000",
                  "LegendIndex": 13,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-040, p. 64 - 200 mg - Atazanavir - PO - 200 mg - Plasma - agg. (n=20)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "ClinPharmReview, AI424-040, p. 64 - 200 mg - Atazanavir - PO - 200 mg - Plasma - agg. (n=20)|Time",
                "Y": "ClinPharmReview, AI424-040, p. 64 - 200 mg - Atazanavir - PO - 200 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#8080FF",
                  "LegendIndex": 14,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-040, p. 64 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=20)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "ClinPharmReview, AI424-040, p. 64 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=20)|Time",
                "Y": "ClinPharmReview, AI424-040, p. 64 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#0000C0",
                  "LegendIndex": 15,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-040, p. 64 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=20)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "ClinPharmReview, AI424-040, p. 64 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=20)|Time",
                "Y": "ClinPharmReview, AI424-040, p. 64 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#00C000",
                  "LegendIndex": 16,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-056, p. 134 - Atazanavir without ritonavir, Day 10 - Atazanavir - PO - 300 mg - Plasma - agg. (n=30)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "ClinPharmReview, AI424-056, p. 134 - Atazanavir without ritonavir, Day 10 - Atazanavir - PO - 300 mg - Plasma - agg. (n=30)|Time",
                "Y": "ClinPharmReview, AI424-056, p. 134 - Atazanavir without ritonavir, Day 10 - Atazanavir - PO - 300 mg - Plasma - agg. (n=30)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#C00000",
                  "LegendIndex": 17,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-076, p. 178 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "ClinPharmReview, AI424-076, p. 178 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)|Time",
                "Y": "ClinPharmReview, AI424-076, p. 178 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#FFFF00",
                  "LegendIndex": 18,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "ClinPharmReview, AI424-076, p. 178 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=66)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "ClinPharmReview, AI424-076, p. 178 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=66)|Time",
                "Y": "ClinPharmReview, AI424-076, p. 178 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=66)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#008080",
                  "LegendIndex": 19,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "Martin 2008 - Atazanavir monotherapy (n = 24) - Atazanavir - PO - 400 mg - Plasma - agg. (n=24)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "Martin 2008 - Atazanavir monotherapy (n = 24) - Atazanavir - PO - 400 mg - Plasma - agg. (n=24)|Time",
                "Y": "Martin 2008 - Atazanavir monotherapy (n = 24) - Atazanavir - PO - 400 mg - Plasma - agg. (n=24)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#800080",
                  "LegendIndex": 20,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "Zhu 2010 - Atazanvir 300 mg twice daily - Atazanavir - PO - 300 mg - Plasma - agg. (n=22)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "Zhu 2010 - Atazanvir 300 mg twice daily - Atazanavir - PO - 300 mg - Plasma - agg. (n=22)|Time",
                "Y": "Zhu 2010 - Atazanvir 300 mg twice daily - Atazanavir - PO - 300 mg - Plasma - agg. (n=22)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#804040",
                  "LegendIndex": 21,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "FDA-ClinPharmReview_AI424-040_800mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "FDA-ClinPharmReview_AI424-040_800mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#00C000",
                  "LegendIndex": 22
                }
              },
              {
                "Name": "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#FF8000",
                  "LegendIndex": 23
                }
              },
              {
                "Name": "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#00C0C0",
                  "LegendIndex": 24
                }
              },
              {
                "Name": "FDA-ClinPharmReview_AI424-014_400mg_YoungMales-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#C000C0",
                  "LegendIndex": 25
                }
              },
              {
                "Name": "FDA-ClinPharmReview_AI424-014_400mg_YoungMales-Atazanavir-Kidney-Urine-Fraction excreted to urine",
                "X": "Time",
                "Y": "FDA-ClinPharmReview_AI424-014_400mg_YoungMales|Organism|Kidney|Urine|Atazanavir|Fraction excreted to urine",
                "CurveOptions": {
                  "yAxisType": "Y2",
                  "Color": "#C04000",
                  "LegendIndex": 26,
                  "LineStyle": "Dash"
                }
              },
              {
                "Name": "Zhu2010_300mg_Atazanavir-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "Zhu2010_300mg_Atazanavir|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#804040",
                  "LegendIndex": 27
                }
              },
              {
                "Name": "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#00FF00",
                  "LegendIndex": 28
                }
              },
              {
                "Name": "FDA-ClinPharmReview_AI424-040_200mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "FDA-ClinPharmReview_AI424-040_200mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#8080FF",
                  "LegendIndex": 29
                }
              },
              {
                "Name": "Agarwala2005b_400mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "Agarwala2005b_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#FF00FF",
                  "LegendIndex": 30
                }
              },
              {
                "Name": "Agarwala2005a_400mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "Agarwala2005a_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#008000",
                  "LegendIndex": 31
                }
              },
              {
                "Name": "FDA-ClinPharmReview_AI424-028_200mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "FDA-ClinPharmReview_AI424-028_200mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#808080",
                  "LegendIndex": 32
                }
              },
              {
                "Name": "FDA-ClinPharmReview_AI424-028_400mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "FDA-ClinPharmReview_AI424-028_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#C0C000",
                  "LegendIndex": 33
                }
              },
              {
                "Name": "Agarwala2003_400mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "Agarwala2003_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#0000FF",
                  "LegendIndex": 34
                }
              },
              {
                "Name": "FDA-ClinPharmReview_AI424-040_400mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "FDA-ClinPharmReview_AI424-040_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#0000C0",
                  "LegendIndex": 35
                }
              },
              {
                "Name": "FDA-ClinPharmReview_AI424-076_400mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "FDA-ClinPharmReview_AI424-076_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#FFFF00",
                  "LegendIndex": 36
                }
              },
              {
                "Name": "FDA-ClinPharmReview_AI424-076_800mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "FDA-ClinPharmReview_AI424-076_800mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#008080",
                  "LegendIndex": 37
                }
              },
              {
                "Name": "Martin2008_400mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "Martin2008_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#800080",
                  "LegendIndex": 38
                }
              },
              {
                "Name": "Acosta2007_300mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "Acosta2007_300mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#FF0000",
                  "LegendIndex": 39
                }
              },
              {
                "Name": "FDA-ClinPharmReview_AI424-056_300mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "FDA-ClinPharmReview_AI424-056_300mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#C00000",
                  "LegendIndex": 40
                }
              },
              {
                "Name": "Zhu 2011 - Treatment A: Atazanavir 400 mg QPM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "Zhu 2011 - Treatment A: Atazanavir 400 mg QPM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)|Time",
                "Y": "Zhu 2011 - Treatment A: Atazanavir 400 mg QPM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#80FF80",
                  "LegendIndex": 41,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "Zhu 2011 - Treatment B: Atazanavir 400 mg QAM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)-Atazanavir-Peripheral Venous Blood-Plasma-ArithmeticMean",
                "X": "Zhu 2011 - Treatment B: Atazanavir 400 mg QAM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)|Time",
                "Y": "Zhu 2011 - Treatment B: Atazanavir 400 mg QAM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean",
                "CurveOptions": {
                  "VisibleInLegend": false,
                  "Color": "#80FF80",
                  "LegendIndex": 42,
                  "LineStyle": "None",
                  "Symbol": "Circle"
                }
              },
              {
                "Name": "Zhu2011_400mg-Atazanavir-Peripheral Venous Blood-Plasma-Concentration",
                "X": "Time",
                "Y": "Zhu2011_400mg|Organism|PeripheralVenousBlood|Atazanavir|Plasma (Peripheral Venous Blood)",
                "CurveOptions": {
                  "Color": "#80FF80",
                  "LegendIndex": 43
                }
              }
            ],
            "Name": "Time Profile",
            "Settings": {
              "SideMarginsEnabled": true,
              "LegendPosition": "None",
              "BackColor": "#FFFFFF",
              "DiagramBackColor": "#FFFFFF"
            }
          }
        }
      ]
    }
  ],
  "ObservedData": [
    {
      "Name": "Agarwala 2003 - Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 550.0
        },
        {
          "Name": "Study Id",
          "Value": "Agarwala 2003"
        },
        {
          "Name": "Reference",
          "Value": "http://www.medadvocates.org/resources/conferences/iasconfpath/ias2003/atv%20pk%20past%2024%20hour%20interval.pdf"
        },
        {
          "Name": "Source",
          "Value": "Figure"
        },
        {
          "Name": "Grouping",
          "Value": "Day 6"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 65.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "400 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-24-48-72-96-120"
        },
        {
          "Name": "Formulation",
          "Value": "Capsule"
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Agarwala 2003 - Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 704.8555
              },
              "Values": [
                0.263503283,
                1.484583,
                2.27686119,
                1.576696,
                1.65475,
                1.192713,
                1.148153,
                0.7124585,
                0.602947354,
                0.4634066,
                0.394772321,
                0.349535018,
                0.286302626,
                0.263503283,
                0.123446494,
                0.060373053,
                0.02142831,
                0.007324659
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Agarwala 2003 - Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.390907973,
            1.2731961,
            3.204996,
            5.36542,
            5.139912,
            4.058743,
            3.274549,
            2.42446184,
            1.719615,
            1.21968293,
            0.963125646,
            0.6135907,
            0.474231839,
            0.390907973,
            0.1365206,
            0.04977024,
            0.01463865,
            0.005003808
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Agarwala 2003 - Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          119.952629,
          121.046516,
          121.060005,
          122.144173,
          123.220184,
          124.158791,
          125.09771,
          126.169952,
          128.183624,
          130.062714,
          131.943375,
          136.108749,
          140.142365,
          144.176926,
          156.004547,
          168.101959,
          180.196213,
          192.023529
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Agarwala 2005a - ATV 400 mg AM (N=15) - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 551.0
        },
        {
          "Name": "Study Id",
          "Value": "Agarwala 2005a"
        },
        {
          "Name": "Reference",
          "Value": "http://www.medadvocates.org/resources/conferences/3rd%20_ias/05-156a_agarwala_086.pdf"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "ATV 400 mg AM (N=15)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 15.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "400 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-24-48-72-96-120"
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Agarwala 2005a - ATV 400 mg AM (N=15) - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.345626,
            5.943076,
            4.274498,
            2.21122432,
            1.45828307,
            1.10487807,
            0.8818324,
            0.5332493,
            0.345626
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Agarwala 2005a - ATV 400 mg AM (N=15) - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          119.981339,
          121.9409,
          123.956451,
          125.953346,
          127.950233,
          129.947128,
          132.0,
          136.012436,
          143.962677
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Agarwala 2005b - ATV 400 mg (Treatment A) - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 552.0
        },
        {
          "Name": "Study Id",
          "Value": "Agarwala 2005b"
        },
        {
          "Name": "Reference",
          "Value": "http://www.medadvocates.org/resources/conferences/3rd%20_ias/05-156b_agarwala_109.pdf"
        },
        {
          "Name": "Source",
          "Value": "Fig. 2"
        },
        {
          "Name": "Grouping",
          "Value": "ATV 400 mg (Treatment A)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 16.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "400 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-24-48-72-96-120"
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Agarwala 2005b - ATV 400 mg (Treatment A) - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.2687558,
            4.674388,
            3.333771,
            1.876698,
            1.432067,
            1.02134907,
            0.779369056,
            0.5195129,
            0.302506
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Agarwala 2005b - ATV 400 mg (Treatment A) - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          119.967079,
          122.008232,
          123.983536,
          125.991768,
          127.967079,
          130.008224,
          132.016464,
          135.967087,
          144.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Martin 2008 - Atazanavir monotherapy (n = 24) - Atazanavir - PO - 400 mg - Plasma - agg. (n=24)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 553.0
        },
        {
          "Name": "Study Id",
          "Value": "Martin 2008"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/19014835"
        },
        {
          "Name": "Source",
          "Value": "Fig. 3"
        },
        {
          "Name": "Grouping",
          "Value": "Atazanavir monotherapy (n = 24)"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 24.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "400 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-24-48-72-96-120-144"
        },
        {
          "Name": "Formulation",
          "Value": "Reyataz® (Bristol Myers Squibb)"
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Martin 2008 - Atazanavir monotherapy (n = 24) - Atazanavir - PO - 400 mg - Plasma - agg. (n=24)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 704.8555
              },
              "Values": [
                0.2556054,
                0.3094171,
                1.775785,
                1.856502,
                1.735426,
                1.183856,
                0.9551568,
                0.6053807,
                0.5381162,
                0.4977582,
                0.3766816,
                0.32287,
                0.2825112
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Martin 2008 - Atazanavir monotherapy (n = 24) - Atazanavir - PO - 400 mg - Plasma - agg. (n=24)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.3901345,
            0.4843049,
            2.973094,
            4.29148,
            4.681614,
            4.278027,
            3.484305,
            1.97757888,
            1.479821,
            1.210762,
            0.9282511,
            0.5919282,
            0.3766816
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Martin 2008 - Atazanavir monotherapy (n = 24) - Atazanavir - PO - 400 mg - Plasma - agg. (n=24)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          144.0,
          144.5,
          145.0,
          145.5,
          146.0,
          147.0,
          148.0,
          150.0,
          152.0,
          154.0,
          156.0,
          162.0,
          168.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Zhu 2011 - Treatment A: Atazanavir 400 mg QPM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 554.0
        },
        {
          "Name": "Study Id",
          "Value": "Zhu 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/20457590"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1A"
        },
        {
          "Name": "Grouping",
          "Value": "Treatment A: Atazanavir 400 mg QPM"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 28.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "400 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-24-48-72-96-120"
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Zhu 2011 - Treatment A: Atazanavir 400 mg QPM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 704.8555
              },
              "Values": [
                0.176056311,
                0.1643192,
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                0.4342723,
                0.352112681,
                0.187793508
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Zhu 2011 - Treatment A: Atazanavir 400 mg QPM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.3051643,
            0.28169018,
            1.983568,
            3.169014,
            3.462441,
            3.65023518,
            3.497653,
            2.699531,
            1.97183108,
            1.314554,
            0.809859037,
            0.293427169
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Zhu 2011 - Treatment A: Atazanavir 400 mg QPM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          120.0,
          120.5,
          121.5,
          122.0,
          122.5,
          123.0,
          124.0,
          126.0,
          128.0,
          132.0,
          136.0,
          144.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Zhu 2011 - Treatment B: Atazanavir 400 mg QAM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 555.0
        },
        {
          "Name": "Study Id",
          "Value": "Zhu 2011"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/20457590"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1B"
        },
        {
          "Name": "Grouping",
          "Value": "Treatment B: Atazanavir 400 mg QAM"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 28.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "400 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-24-48-72-96-120"
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Zhu 2011 - Treatment B: Atazanavir 400 mg QAM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 704.8555
              },
              "Values": [
                0.1897233,
                0.1897233,
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                0.01185791,
                0.5335973,
                0.2964427,
                0.249011889,
                0.201580986
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Zhu 2011 - Treatment B: Atazanavir 400 mg QAM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.308300436,
            0.308300436,
            3.652174,
            4.49407053,
            4.470356,
            4.434783,
            3.806324,
            2.09881377,
            1.3992089,
            0.7826087,
            0.486165971,
            0.3201581
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Zhu 2011 - Treatment B: Atazanavir 400 mg QAM - Atazanavir - PO - 400 mg - Plasma - agg. (n=28)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          120.0,
          120.5,
          121.5,
          122.0,
          122.5,
          123.0,
          124.0,
          126.0,
          128.0,
          132.0,
          136.0,
          144.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-001, p. 51 - 100 mg - Atazanavir - PO - 100 mg - Plasma - agg. (n=6)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 556.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-001, p. 51"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P1.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 51"
        },
        {
          "Name": "Grouping",
          "Value": "100 mg"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 6.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "100 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "capsule"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-001, p. 51 - 100 mg - Atazanavir - PO - 100 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.0115062,
            0.03149255,
            0.03776252,
            0.04101127,
            0.04101127,
            0.038391,
            0.03477112,
            0.03653625,
            0.03149255,
            0.01983769,
            0.00656454,
            0.001461755
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-001, p. 51 - 100 mg - Atazanavir - PO - 100 mg - Plasma - agg. (n=6)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.5986837,
          0.7488421,
          0.9409279,
          1.399204,
          2.124645,
          3.027545,
          4.019176,
          5.019582,
          6.098968,
          7.975949,
          11.90054,
          17.97806
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-001, p. 51 - 300 mg - Atazanavir - PO - 300 mg - Plasma - agg. (n=5)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 557.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-001, p. 51"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P1.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 51"
        },
        {
          "Name": "Grouping",
          "Value": "300 mg"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 5.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "300 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "capsule"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-001, p. 51 - 300 mg - Atazanavir - PO - 300 mg - Plasma - agg. (n=5)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.302194625,
            0.7012585,
            1.02506793,
            0.9755449,
            0.8135688,
            0.5848239,
            0.479737431,
            0.3683904,
            0.2320553,
            0.1050764,
            0.0309770089,
            0.01229152,
            0.004718839,
            0.001199093
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-001, p. 51 - 300 mg - Atazanavir - PO - 300 mg - Plasma - agg. (n=5)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.6103843,
          0.9321525,
          1.498659,
          2.130495,
          3.02657,
          4.095231,
          5.081011,
          6.062891,
          8.121232,
          12.06435,
          18.06777,
          23.99805,
          30.01706,
          36.0117
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-001, p. 51 - 600 mg - Atazanavir - PO - 600 mg - Plasma - agg. (n=6)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 558.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-001, p. 51"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P1.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 51"
        },
        {
          "Name": "Grouping",
          "Value": "600 mg"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 6.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "600 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "capsule"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-001, p. 51 - 600 mg - Atazanavir - PO - 600 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            2.226744,
            2.899784,
            2.852313,
            2.378724,
            2.05035019,
            1.574464,
            1.16977,
            0.898266137,
            0.4490862,
            0.1811609,
            0.1016643,
            0.04381038,
            0.02226744
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-001, p. 51 - 600 mg - Atazanavir - PO - 600 mg - Plasma - agg. (n=6)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          1.091086,
          1.560088,
          2.193873,
          2.999269,
          4.078654,
          5.060534,
          6.040465,
          8.110506,
          11.9688,
          18.08142,
          24.12286,
          30.05802,
          36.00293
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-001, p. 51 - 900 mg - Atazanavir - PO - 900 mg - Plasma - agg. (n=6)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 559.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-001, p. 51"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P1.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 51"
        },
        {
          "Name": "Grouping",
          "Value": "900 mg"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 6.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "900 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "capsule"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-001, p. 51 - 900 mg - Atazanavir - PO - 900 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            4.381039,
            5.42958975,
            4.91763449,
            4.101127,
            2.948045,
            2.499479,
            1.857023,
            1.077105,
            0.5124806,
            0.3123372,
            0.153595984,
            0.07553291
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-001, p. 51 - 900 mg - Atazanavir - PO - 900 mg - Plasma - agg. (n=6)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          1.493784,
          1.95986,
          2.951491,
          4.119606,
          5.006907,
          5.994637,
          8.062729,
          12.02048,
          18.0521679,
          24.09848,
          30.04144,
          36.07508
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-001, p. 51 - 200 mg - Atazanavir - PO - 1200 mg - Plasma - agg. (n=6)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 560.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-001, p. 51"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P1.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 51"
        },
        {
          "Name": "Grouping",
          "Value": "200 mg"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 6.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "1200 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "capsule"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-001, p. 51 - 200 mg - Atazanavir - PO - 1200 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            2.499479,
            4.238773,
            4.238773,
            3.71443319,
            3.254954,
            2.54107785,
            1.857023,
            1.574464,
            0.9438661,
            0.464158922,
            0.2067341,
            0.1160155,
            0.04999479
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-001, p. 51 - 200 mg - Atazanavir - PO - 1200 mg - Plasma - agg. (n=6)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.8258715,
          1.491834,
          2.035914,
          2.934915,
          4.015276,
          4.998131,
          6.067766,
          8.052978,
          12.10336,
          18.0463085,
          24.0741,
          30.11554,
          36.0507
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-040, p. 64 - 200 mg - Atazanavir - PO - 200 mg - Plasma - agg. (n=20)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 561.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-040, p. 64"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P2.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 64"
        },
        {
          "Name": "Grouping",
          "Value": "200 mg"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 20.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "200 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-24-48-72-96"
        },
        {
          "Name": "Formulation",
          "Value": "capsule"
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "ClinPharmReview, AI424-040, p. 64 - 200 mg - Atazanavir - PO - 200 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 704.8555
              },
              "Values": [
                0.06896489,
                0.040101558,
                0.3164328,
                0.524905562,
                0.6611023,
                0.537506,
                1.42959487,
                0.402107716,
                0.2548062,
                0.2615397,
                0.174726814,
                0.143759191,
                0.1135808,
                0.0665351,
                0.0414257571
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-040, p. 64 - 200 mg - Atazanavir - PO - 200 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.0480940826,
            0.04614355,
            0.231440708,
            0.7544552,
            1.22753,
            1.12962091,
            1.2453891,
            0.809909165,
            0.6764423,
            0.505493,
            0.3243893,
            0.2294415,
            0.157832012,
            0.08947934,
            0.04127644
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-040, p. 64 - 200 mg - Atazanavir - PO - 200 mg - Plasma - agg. (n=20)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          95.99613,
          96.505,
          97.01221,
          97.47041,
          97.9912643,
          98.45997,
          98.93277,
          99.94261,
          100.997345,
          101.971123,
          104.000259,
          106.031616,
          108.023117,
          112.049454,
          120.031883
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-040, p. 64 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=20)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 562.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-040, p. 64"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P2.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 64"
        },
        {
          "Name": "Grouping",
          "Value": "400 mg"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 20.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "400 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-24-48-72-96"
        },
        {
          "Name": "Formulation",
          "Value": "capsule"
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "ClinPharmReview, AI424-040, p. 64 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 704.8555
              },
              "Values": [
                0.1314822,
                0.120898508,
                0.9861353,
                1.61039793,
                1.697945,
                1.066455,
                0.9300435,
                1.54369211,
                0.681202531,
                0.6069391,
                0.533596635,
                0.4194472,
                0.3323951,
                0.2336229,
                0.15527381
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-040, p. 64 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.2098598,
            0.215839088,
            1.24397588,
            3.384883,
            4.28824043,
            4.001618,
            3.73389983,
            3.38980579,
            2.39614987,
            1.790681,
            1.284251,
            0.9210682,
            0.642482,
            0.4014605,
            0.215780184
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-040, p. 64 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=20)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          95.99037,
          96.50082,
          96.97196,
          97.46528,
          97.94124,
          98.48869,
          98.91849,
          99.97512,
          100.947632,
          101.99984,
          103.992294,
          106.023956,
          108.055,
          112.083527,
          120.03022
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-040, p. 64 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=20)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 563.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-040, p. 64"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P2.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 64"
        },
        {
          "Name": "Grouping",
          "Value": "800 mg"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 20.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "800 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-24-48-72-96"
        },
        {
          "Name": "Formulation",
          "Value": "capsule"
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "ClinPharmReview, AI424-040, p. 64 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 704.8555
              },
              "Values": [
                0.7784695,
                0.8074333,
                3.19658113,
                2.715521,
                2.546102,
                2.423367,
                3.151929,
                2.488208,
                2.049268,
                1.62518108,
                1.53448,
                1.31112409,
                1.310689,
                0.9509586,
                0.8873856
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-040, p. 64 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            1.08193791,
            1.243637,
            4.59424353,
            8.013163,
            8.95782852,
            8.017349,
            7.586017,
            6.605524,
            5.44071,
            4.544019,
            3.693165,
            2.87911,
            2.34011221,
            1.63413906,
            1.052324
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-040, p. 64 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=20)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          95.9884,
          96.5013657,
          96.96242,
          97.52406,
          97.95797,
          98.42604,
          98.9345856,
          99.95105,
          100.966255,
          101.981773,
          103.977066,
          106.010628,
          108.084351,
          112.03698,
          120.0662
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-002, p. 55 - 100 mg - Atazanavir - PO - 100 mg - Plasma - agg. (n=6)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 564.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-002, p. 55"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P1.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 56, BID"
        },
        {
          "Name": "Grouping",
          "Value": "100 mg"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 6.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "100 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-12-24-36-48-60-72-84-96-108-120-132-144-156-168-180-192-204-216-228-240-252-264-276-288-300-312"
        },
        {
          "Name": "Formulation",
          "Value": "capsule"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-002, p. 55 - 100 mg - Atazanavir - PO - 100 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.006987003,
            0.007382768,
            0.0111791007,
            0.01692758,
            0.02708388,
            0.0302356016,
            0.0249191411,
            0.02288097,
            0.01662453,
            0.0134555595,
            0.00685521774,
            0.001175887,
            0.06734853,
            0.06488737,
            0.07795903,
            0.148299113,
            0.262094617,
            0.3326082,
            0.3511841,
            0.3257984,
            0.2807979,
            0.2207847,
            0.17680499,
            0.1362602,
            0.0614339225,
            0.06229641,
            0.05900594,
            0.0708076954,
            0.08974919,
            0.1158429,
            0.131685,
            0.144353,
            0.1499213,
            0.1321864,
            0.108356692,
            0.09046827,
            0.06539156,
            0.03007823
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-002, p. 55 - 100 mg - Atazanavir - PO - 100 mg - Plasma - agg. (n=6)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.25,
          0.5,
          0.75,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          12.0,
          144.0,
          144.25,
          144.5,
          144.75,
          145.0,
          145.5,
          146.0,
          147.0,
          148.0,
          149.0,
          150.0,
          152.0,
          156.0,
          312.0,
          312.25,
          312.5,
          312.75,
          313.0,
          313.5,
          314.0,
          315.0,
          316.0,
          317.0,
          318.0,
          320.0,
          324.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-002, p. 55 - 200 mg - Atazanavir - PO - 200 mg - Plasma - agg. (n=6)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 565.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-002, p. 55"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P1.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 56, BID"
        },
        {
          "Name": "Grouping",
          "Value": "200 mg"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 6.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "200 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-12-24-36-48-60-72-84-96-108-120-132-144-156-168-180-192-204-216-228-240-252-264-276-288-300-312"
        },
        {
          "Name": "Formulation",
          "Value": "capsule"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-002, p. 55 - 200 mg - Atazanavir - PO - 200 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.007113036,
            0.1039149,
            0.2650899,
            0.3120322,
            0.2807373,
            0.2350439,
            0.2277872,
            0.1625516,
            0.1364014,
            0.108444504,
            0.07499796,
            0.03522668,
            0.358841181,
            0.3271893,
            0.6110648,
            1.618344,
            1.94413793,
            1.739762,
            1.675735,
            1.269879,
            1.055049,
            0.892791867,
            0.7019271,
            0.4584873,
            0.2308184,
            0.2926698,
            0.2772216,
            0.61774236,
            1.126756,
            1.428224,
            1.40352786,
            1.30591106,
            1.090238,
            0.9269021,
            0.7598354,
            0.657891154,
            0.426332,
            0.210895091
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-002, p. 55 - 200 mg - Atazanavir - PO - 200 mg - Plasma - agg. (n=6)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.25,
          0.5,
          0.75,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          12.0,
          144.0,
          144.25,
          144.5,
          144.75,
          145.0,
          145.5,
          146.0,
          147.0,
          148.0,
          149.0,
          150.0,
          152.0,
          156.0,
          312.0,
          312.25,
          312.5,
          312.75,
          313.0,
          313.5,
          314.0,
          315.0,
          316.0,
          317.0,
          318.0,
          320.0,
          324.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-014, p. 77 - Young Females - Atazanavir - PO - 400 mg - Plasma - agg. (n=14)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 566.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-014, p. 77"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P2.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 78"
        },
        {
          "Name": "Grouping",
          "Value": "Young Females"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 14.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "400 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "capsule"
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-014, p. 77 - Young Females - Atazanavir - PO - 400 mg - Plasma - agg. (n=14)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.05230854,
            0.484561324,
            1.774314,
            2.93255186,
            3.0067482,
            2.523798,
            2.035832,
            1.36387408,
            0.94840306,
            0.5262913,
            0.3909384,
            0.243110612,
            0.1680946,
            0.1087425
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-014, p. 77 - Young Females - Atazanavir - PO - 400 mg - Plasma - agg. (n=14)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          1.0,
          1.5,
          2.0,
          2.5,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          10.0,
          12.0,
          16.0,
          20.0,
          24.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-014, p. 77 - Young Males - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 567.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-014, p. 77"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P2.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 78"
        },
        {
          "Name": "Grouping",
          "Value": "Young Males"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 15.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "400 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "capsule"
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-014, p. 77 - Young Males - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.0259421282,
            0.5539344,
            1.495321,
            1.947099,
            2.023281,
            1.993596,
            1.52488494,
            1.24664092,
            0.9043038,
            0.6372207,
            0.414461225,
            0.280626565,
            0.1528258,
            0.0889423043,
            0.06148055
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-014, p. 77 - Young Males - Atazanavir - PO - 400 mg - Plasma - agg. (n=15)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.5,
          1.0,
          1.5,
          2.0,
          2.5,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          10.0,
          12.0,
          16.0,
          20.0,
          24.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-015, p. 81 - Normal subjects - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 568.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-015, p. 81"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P2.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 84"
        },
        {
          "Name": "Grouping",
          "Value": "Normal subjects"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 16.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "400 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "capsule"
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "ClinPharmReview, AI424-015, p. 81 - Normal subjects - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 704.8555
              },
              "Values": [
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                0.8747253,
                0.675384939,
                0.6008683,
                0.470561773,
                0.30067718,
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                "NaN",
                0.003665797,
                0.002383957
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-015, p. 81 - Normal subjects - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.0009010012,
            0.01371434,
            0.1609762,
            0.5417439,
            1.161055,
            1.612042,
            1.306997,
            1.006389,
            0.788139939,
            0.5272567,
            0.248676687,
            0.1253634,
            0.0738563,
            0.02193046,
            0.009213131,
            0.002002263,
            0.0008708458
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-015, p. 81 - Normal subjects - Atazanavir - PO - 400 mg - Plasma - agg. (n=16)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.25,
          0.5,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          12.0,
          18.0,
          24.0,
          36.0,
          48.0,
          60.0,
          72.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-004, p. 94 - Treatment A - Atazanavir - PO - 400 mg - Plasma - agg. (n=32)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 569.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-004, p. 94"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P2.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 95"
        },
        {
          "Name": "Grouping",
          "Value": "Treatment A"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 32.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "400 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "capsule"
        },
        {
          "Name": "Food state",
          "Value": "Fasted"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-004, p. 94 - Treatment A - Atazanavir - PO - 400 mg - Plasma - agg. (n=32)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.00811301,
            0.107313596,
            0.5022855,
            1.014487,
            1.295859,
            1.147174,
            0.9267733,
            0.6937596,
            0.5436467,
            0.4131931,
            0.2823701,
            0.1959386,
            0.1318606,
            0.05373392,
            0.03410638
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-004, p. 94 - Treatment A - Atazanavir - PO - 400 mg - Plasma - agg. (n=32)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          0.25,
          0.5,
          0.75,
          1.0,
          1.5,
          2.0,
          3.0,
          4.0,
          5.0,
          6.0,
          8.0,
          10.0,
          12.0,
          18.0,
          24.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Zhu 2010 - Atazanvir 300 mg twice daily - Atazanavir - PO - 300 mg - Plasma - agg. (n=22)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 576.0
        },
        {
          "Name": "Study Id",
          "Value": "Zhu 2010"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21149917"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1A"
        },
        {
          "Name": "Grouping",
          "Value": "Atazanvir 300 mg twice daily"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 22.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "300 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "120-132-144-156-168-180-192-204-216-228-240-252-264-276"
        },
        {
          "Name": "Formulation",
          "Value": "Reyataz® (Bristol Myers Squibb)"
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Zhu 2010 - Atazanvir 300 mg twice daily - Atazanavir - PO - 300 mg - Plasma - agg. (n=22)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 704.8555
              },
              "Values": [
                0.5346062,
                1.219571,
                1.436754,
                0.8520288,
                0.7016702,
                0.4677803,
                0.467780024,
                0.400954485
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Zhu 2010 - Atazanvir 300 mg twice daily - Atazanavir - PO - 300 mg - Plasma - agg. (n=22)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            1.58711207,
            2.455847,
            5.229117,
            4.560859,
            3.97613382,
            2.52267313,
            1.93794787,
            1.26968992
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Zhu 2010 - Atazanvir 300 mg twice daily - Atazanavir - PO - 300 mg - Plasma - agg. (n=22)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          264.0,
          265.0,
          266.0,
          267.0,
          268.0,
          270.0,
          272.0,
          276.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "Acosta 2007 - Period 1 - Atazanavir - PO - 300 mg - Plasma - agg. (n=10)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 580.0
        },
        {
          "Name": "Study Id",
          "Value": "Acosta 2007"
        },
        {
          "Name": "Reference",
          "Value": "https://www.ncbi.nlm.nih.gov/pubmed/17576825"
        },
        {
          "Name": "Source",
          "Value": "Fig. 1"
        },
        {
          "Name": "Grouping",
          "Value": "Period 1"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 10.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "300 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-12-24-36-48-60-72-84-96-108-120-132-144-156-168"
        },
        {
          "Name": "Formulation",
          "Value": "150 mg capsule"
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "Acosta 2007 - Period 1 - Atazanavir - PO - 300 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 704.8555
              },
              "Values": [
                0.999406457,
                0.8790583,
                1.469151,
                1.189533,
                1.318929,
                1.534817,
                1.008717,
                0.7954764,
                0.6551184,
                0.6215414
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "Acosta 2007 - Period 1 - Atazanavir - PO - 300 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            1.188273,
            1.44016707,
            2.60912418,
            3.069571,
            3.402505,
            2.842337,
            2.20712686,
            1.538141,
            1.073286,
            0.9089452
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "Acosta 2007 - Period 1 - Atazanavir - PO - 300 mg - Plasma - agg. (n=10)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          168.023636,
          169.054031,
          170.054123,
          171.052185,
          172.049988,
          173.046478,
          174.042679,
          176.0034,
          178.0607,
          180.0224
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-028, p. 128 - A-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 581.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-028, p. 128"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P3.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 129, upper panel"
        },
        {
          "Name": "Grouping",
          "Value": "A-Day 6"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 8.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "200 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-24-48-72-96-120"
        },
        {
          "Name": "Formulation",
          "Value": "200 mg capsules (Batch #C99274)"
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-028, p. 128 - A-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.05314065,
            0.04231789,
            0.1554463,
            0.5321257,
            1.15752506,
            1.53488791,
            1.368999,
            1.014276,
            0.8300467,
            0.6603217,
            0.4119116,
            0.2606814,
            0.1745166,
            0.0793602839,
            0.03523748
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-028, p. 128 - A-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          120.0,
          120.5,
          121.0,
          121.5,
          122.0,
          122.5,
          123.0,
          124.0,
          125.0,
          126.0,
          128.0,
          130.0,
          132.0,
          136.0,
          144.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-028, p. 128 - B-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 582.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-028, p. 128"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P3.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 129, upper panel"
        },
        {
          "Name": "Grouping",
          "Value": "B-Day 6"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 8.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "200 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-24-48-72-96-120"
        },
        {
          "Name": "Formulation",
          "Value": "200 mg capsules (Batch #C99274)"
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-028, p. 128 - B-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.0362584479,
            0.0377876572,
            0.0974401459,
            0.517340243,
            1.12507391,
            1.241138,
            1.204957,
            0.8929667,
            0.7625662,
            0.581494868,
            0.3947374,
            0.249876514,
            0.162283108,
            0.08282365,
            0.03146925
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-028, p. 128 - B-Day 6 - Atazanavir - PO - 200 mg - Plasma - agg. (n=8)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          120.0,
          120.5,
          121.0,
          121.5,
          122.0,
          122.5,
          123.0,
          124.0,
          125.0,
          126.0,
          128.0,
          130.0,
          132.0,
          136.0,
          144.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-028, p. 128 - C-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 583.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-028, p. 128"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P3.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 129, lower panel"
        },
        {
          "Name": "Grouping",
          "Value": "C-Day 6"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 8.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "400 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-24-48-72-96-120"
        },
        {
          "Name": "Formulation",
          "Value": "200 mg capsules (Batch #C99274)"
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-028, p. 128 - C-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.1842253,
            0.159659311,
            1.200078,
            4.75857639,
            5.401809,
            4.955954,
            4.354939,
            3.663426,
            3.125826,
            2.28055215,
            1.50329387,
            0.9227382,
            0.681405246,
            0.2876778,
            0.144684613
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-028, p. 128 - C-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          120.0,
          120.5,
          121.0,
          121.5,
          122.0,
          122.5,
          123.0,
          124.0,
          125.0,
          126.0,
          128.0,
          130.0,
          132.0,
          136.0,
          144.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-028, p. 128 - D-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 584.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-028, p. 128"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P3.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 129, lower panel"
        },
        {
          "Name": "Grouping",
          "Value": "D-Day 6"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 8.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "400 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-24-48-72-96-120"
        },
        {
          "Name": "Formulation",
          "Value": "200 mg capsules (Batch #C99274)"
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-028, p. 128 - D-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.224809,
            0.294169575,
            0.7724532,
            2.73343086,
            4.30313,
            4.816469,
            4.29295,
            3.460545,
            2.788849,
            2.064852,
            1.3804189,
            0.949460566,
            0.6910724,
            0.3663426,
            0.17161
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-028, p. 128 - D-Day 6 - Atazanavir - PO - 400 mg - Plasma - agg. (n=8)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          120.0,
          120.5,
          121.0,
          121.5,
          122.0,
          122.5,
          123.0,
          124.0,
          125.0,
          126.0,
          128.0,
          130.0,
          132.0,
          136.0,
          144.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-056, p. 134 - Atazanavir without ritonavir, Day 10 - Atazanavir - PO - 300 mg - Plasma - agg. (n=30)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 585.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-056, p. 134"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P3.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 135"
        },
        {
          "Name": "Grouping",
          "Value": "Atazanavir without ritonavir, Day 10"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 30.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "300 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-24-48-72-96-120-144-168-192-216"
        },
        {
          "Name": "Formulation",
          "Value": "100 mg capsules (Batch #C99178)"
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "ClinPharmReview, AI424-056, p. 134 - Atazanavir without ritonavir, Day 10 - Atazanavir - PO - 300 mg - Plasma - agg. (n=30)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 704.8555
              },
              "Values": [
                0.1250763,
                0.196849108,
                1.19308,
                1.446573,
                1.55675507,
                1.684885,
                1.76106107,
                1.004558,
                0.7006741,
                0.5272378,
                0.438584417,
                0.293045431,
                0.2282557,
                0.1358998,
                0.107063
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-056, p. 134 - Atazanavir without ritonavir, Day 10 - Atazanavir - PO - 300 mg - Plasma - agg. (n=30)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.1531764,
            0.197757408,
            0.6693192,
            1.40499806,
            2.18846416,
            2.94868183,
            3.155993,
            2.400365,
            1.8892,
            1.29715407,
            0.9130627,
            0.626468062,
            0.4190316,
            0.221953511,
            0.13363041
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-056, p. 134 - Atazanavir without ritonavir, Day 10 - Atazanavir - PO - 300 mg - Plasma - agg. (n=30)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          216.0,
          216.5,
          217.0,
          217.5,
          218.0,
          218.5,
          219.0,
          220.0,
          221.0,
          222.0,
          224.0,
          226.0,
          228.0,
          234.062744,
          240.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-076, p. 178 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 586.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-076, p. 178"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P4.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 179"
        },
        {
          "Name": "Grouping",
          "Value": "400 mg"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 65.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "400 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-24-48-72-96-120"
        },
        {
          "Name": "Formulation",
          "Value": "200 mg capsules (Batch #N00024)"
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "ClinPharmReview, AI424-076, p. 178 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 704.8555
              },
              "Values": [
                0.2759236,
                "NaN",
                "NaN",
                1.781022,
                1.445491,
                1.46416092,
                1.34051692,
                0.7006941,
                0.673124,
                0.493472278,
                0.4216158,
                0.3524667,
                0.314685076,
                0.266410172,
                0.1298246,
                0.0646794438,
                0.02302757,
                0.00727167539
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-076, p. 178 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.369267374,
            1.17472494,
            3.03925085,
            5.309809,
            4.68919,
            3.734517,
            2.974325,
            2.272674,
            1.598362,
            1.171611,
            0.8767704,
            0.5792286,
            0.442213416,
            0.374411,
            0.132735789,
            0.04515358,
            0.01356922,
            0.004429182
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-076, p. 178 - 400 mg - Atazanavir - PO - 400 mg - Plasma - agg. (n=65)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          120.0,
          121.0,
          121.5,
          122.0,
          123.0,
          124.0,
          125.0,
          126.0,
          128.0,
          130.0,
          132.0,
          136.0,
          140.0,
          144.0,
          156.0,
          168.0,
          180.0,
          192.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-076, p. 178 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=66)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 587.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-076, p. 178"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P4.pdf"
        },
        {
          "Name": "Source",
          "Value": "PK profile shown on p. 179"
        },
        {
          "Name": "Grouping",
          "Value": "800 mg"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 66.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Peripheral Venous Blood"
        },
        {
          "Name": "Compartment",
          "Value": "Plasma"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": "800 mg"
        },
        {
          "Name": "Times of Administration [h]",
          "Value": "0-24-48-72-96-120"
        },
        {
          "Name": "Formulation",
          "Value": "200 mg capsules (Batch #N00024)"
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "RelatedColumns": [
            {
              "Name": "Var",
              "QuantityInfo": {
                "Name": "Var",
                "Path": "ClinPharmReview, AI424-076, p. 178 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=66)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticStdDev"
              },
              "DataInfo": {
                "Origin": "ObservationAuxiliary",
                "AuxiliaryType": "ArithmeticStdDev",
                "Date": "0001-01-01T00:00:00",
                "MolWeight": 704.8555
              },
              "Values": [
                0.870897532,
                "NaN",
                "NaN",
                3.236767,
                2.685802,
                2.189063,
                1.66910589,
                1.58817708,
                1.22174191,
                1.198752,
                1.068143,
                1.01682389,
                0.8649302,
                0.3441633,
                0.2606264,
                0.120526806,
                0.0410581566
              ],
              "Dimension": "Concentration (mass)",
              "Unit": "mg/l"
            }
          ],
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-076, p. 178 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=66)|ObservedData|Peripheral Venous Blood|Plasma|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            1.60203,
            4.05965853,
            7.546556,
            10.50189,
            8.715749,
            6.523181,
            5.41460037,
            4.051994,
            3.36229587,
            2.848031,
            2.08628583,
            1.766335,
            1.5910511,
            0.5087171,
            0.2359636,
            0.08718763,
            0.0267481711
          ],
          "Dimension": "Concentration (mass)",
          "Unit": "mg/l"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-076, p. 178 - 800 mg - Atazanavir - PO - 800 mg - Plasma - agg. (n=66)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          120.0,
          121.0,
          121.5,
          122.0,
          124.0,
          125.0,
          126.0,
          128.0,
          130.0,
          132.0,
          136.0,
          140.0,
          144.0,
          156.0,
          168.0,
          180.0,
          192.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    },
    {
      "Name": "ClinPharmReview, AI424-029, p. 47 - Urinary radioactivity - Atazanavir - PO - 400  - Urine - agg. (n=12)",
      "ExtendedProperties": [
        {
          "Name": "DB Version",
          "Value": "OSP DATABASE"
        },
        {
          "Name": "ID",
          "Value": 133.0
        },
        {
          "Name": "Study Id",
          "Value": "ClinPharmReview, AI424-029, p. 47"
        },
        {
          "Name": "Reference",
          "Value": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/21-567_Reyataz_BioPharmr_P1.pdf"
        },
        {
          "Name": "Source",
          "Value": "Text (p. 49)"
        },
        {
          "Name": "Grouping",
          "Value": "Urinary radioactivity"
        },
        {
          "Name": "Data type",
          "Value": "aggregated"
        },
        {
          "Name": "N",
          "Value": 12.0
        },
        {
          "Name": "Molecule",
          "Value": "Atazanavir"
        },
        {
          "Name": "Species",
          "Value": "Human"
        },
        {
          "Name": "Organ",
          "Value": "Kidney"
        },
        {
          "Name": "Compartment",
          "Value": "Urine"
        },
        {
          "Name": "Route",
          "Value": "PO"
        },
        {
          "Name": "Dose",
          "Value": 400.0
        },
        {
          "Name": "Times of Administration [h]",
          "Value": 0.0
        },
        {
          "Name": "Formulation",
          "Value": "."
        },
        {
          "Name": "Food state",
          "Value": "Fed"
        },
        {
          "Name": "Comment",
          "Value": "."
        }
      ],
      "Columns": [
        {
          "Name": "Avg",
          "QuantityInfo": {
            "Name": "Avg",
            "Path": "ClinPharmReview, AI424-029, p. 47 - Urinary radioactivity - Atazanavir - PO - 400  - Urine - agg. (n=12)|ObservedData|Kidney|Urine|Atazanavir|ArithmeticMean"
          },
          "DataInfo": {
            "Origin": "Observation",
            "AuxiliaryType": "Undefined",
            "Date": "0001-01-01T00:00:00",
            "MolWeight": 704.8555
          },
          "Values": [
            0.07
          ],
          "Dimension": "Fraction"
        }
      ],
      "BaseGrid": {
        "Name": "Time",
        "QuantityInfo": {
          "Name": "Time",
          "Path": "ClinPharmReview, AI424-029, p. 47 - Urinary radioactivity - Atazanavir - PO - 400  - Urine - agg. (n=12)|Time",
          "Type": "Time"
        },
        "DataInfo": {
          "Origin": "BaseGrid",
          "AuxiliaryType": "Undefined",
          "Date": "0001-01-01T00:00:00"
        },
        "Values": [
          168.0
        ],
        "Dimension": "Time",
        "Unit": "h"
      }
    }
  ],
  "SimulationClassifications": [
    {
      "Name": "Atazanavir Single Dose",
      "Classifiables": [
        "FDA-ClinPharmReview_AI424-004_400mg_TreatmentA",
        "FDA-ClinPharmReview_AI424-014_400mg_YoungFemales",
        "FDA-ClinPharmReview_AI424-014_400mg_YoungMales",
        "FDA-ClinPharmReview_AI424-015_400mg_NormalSubjects"
      ]
    },
    {
      "Name": "Atazanavir Multiple Dose",
      "Classifiables": [
        "Acosta2007_300mg",
        "Agarwala2003_400mg",
        "Agarwala2005a_400mg",
        "Agarwala2005b_400mg",
        "FDA-ClinPharmReview_AI424-028_200mg",
        "FDA-ClinPharmReview_AI424-028_400mg",
        "FDA-ClinPharmReview_AI424-040_200mg",
        "FDA-ClinPharmReview_AI424-040_400mg",
        "FDA-ClinPharmReview_AI424-040_800mg",
        "FDA-ClinPharmReview_AI424-056_300mg",
        "FDA-ClinPharmReview_AI424-076_400mg",
        "FDA-ClinPharmReview_AI424-076_800mg",
        "Martin2008_400mg",
        "Zhu2011_400mg",
        "Zhu2010_300mg_Atazanavir"
      ]
    }
  ]
}